Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
MAC.MDM.complement_resolving: Meta traits — page 3
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 1,931 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 2,001–3,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2001 | CNTN4 levels | PROLV000478 | 3.42 | Protein levels | Myeloid | 28 | 0 | 1 | 5 | |
| 2002 | PGLYRP1 levels | PROLV001546 | 3.41 | Protein levels | Myeloid | 82 | 4 | 8 | 9 | |
| 2003 | DNER levels | PROLV000637 | 3.40 | Protein levels | Vascular | 69 | 1 | 6 | 18 | |
| 2004 | Phosphatidylethanolamines | LIPID000059 | 3.40 | Lipids | Hepatocyte | 24 | 0 | 1 | 3 | |
| 2005 | STX8 levels | PROLV001970 | 3.40 | Protein levels | Myeloid | 0 | 3 | 5 | 14 | |
| 2006 | Gait abnormality | NEURO000014 | 3.38 | Neurologic | Neural / glial | 0 | 4 | 11 | 17 | |
| 2007 | IGFBP6/PTGDS ratio | PRORT001337 | 3.37 | Protein ratios | Myeloid | 19 | 2 | 7 | 18 | |
| 2008 | CDKN1A/TACC3 ratio | PRORT000572 | 3.35 | Protein ratios | B / plasma cell | 20 | 4 | 12 | 29 | |
| 2009 | CD55/ITGB1 ratio | PRORT000470 | 3.35 | Protein ratios | Vascular | 51 | 2 | 8 | 22 | |
| 2010 | IGF1 levels | PROLV001025 | 3.35 | Protein levels | Hepatocyte | 1,341 | 1 | 7 | 13 | |
| 2011 | CD84/DKK1 ratio | PRORT000522 | 3.34 | Protein ratios | Myeloid | 20 | 3 | 7 | 22 | |
| 2012 | F7 levels | PROLV000748 | 3.34 | Protein levels | Hepatocyte | 89 | 1 | 8 | 15 | |
| 2013 | PLXNB3/SNAP23 ratio | PRORT001691 | 3.34 | Protein ratios | Myeloid | 0 | 5 | 13 | 36 | |
| 2014 | EDAR/F11R ratio | PRORT000968 | 3.34 | Protein ratios | Myeloid | 23 | 3 | 7 | 20 | |
| 2015 | Liver enzyme levels, ALP | HPBIL000012 | 3.34 | Hepatopancreatobiliary | Hepatocyte | 1,521 | 1 | 5 | 16 | |
| 2016 | KIR2DL3 levels | PROLV001142 | 3.33 | Protein levels | Lymphocyte | 134 | 2 | 10 | 19 | |
| 2017 | BPIFA2 levels | PROLV000209 | 3.33 | Protein levels | Salivary epithelium | 66 | 0 | 4 | 8 | |
| 2018 | DAG1/DBNL ratio | PRORT000844 | 3.33 | Protein ratios | Muscle / cardiac | 1 | 4 | 15 | 25 | |
| 2019 | TNFRSF8 levels | PROLV002073 | 3.33 | Protein levels | Lymphocyte | 95 | 2 | 20 | 28 | |
| 2020 | GPD1 levels | PROLV000921 | 3.33 | Protein levels | Neural / glial | 0 | 3 | 7 | 11 | |
| 2021 | Surgical history | MISCL000031 | 3.32 | Miscellaneous | Hematopoietic progenitor | 22 | 1 | 1 | 6 | |
| 2022 | Sarcoidosis | IMMUN000080 | 3.32 | Immunologic | Lymphocyte | 82 | 3 | 15 | 37 | |
| 2023 | CAPG levels | PROLV000262 | 3.32 | Protein levels | Lymphocyte | 34 | 3 | 16 | 42 | |
| 2024 | ITGA2 levels | PROLV001105 | 3.32 | Protein levels | Vascular | 76 | 3 | 13 | 27 | |
| 2025 | Heart rate response to exercise | CARDI000025 | 3.32 | Cardiac | Vascular | 12 | 0 | 6 | 5 | |
| 2026 | Cardiovascular disease | CARDI000035 | 3.32 | Cardiac | Vascular | 145 | 3 | 8 | 11 | |
| 2027 | ANGPTL3 levels | PROLV000097 | 3.31 | Protein levels | Hepatocyte | 67 | 1 | 10 | 15 | |
| 2028 | CST3/TIMP1 ratio | PRORT000789 | 3.31 | Protein ratios | Myeloid | 25 | 3 | 8 | 10 | |
| 2029 | Cholesterol, remnant | LIPID000013 | 3.30 | Lipids | Hepatocyte | 224 | 1 | 9 | 14 | |
| 2030 | Synovium, tendon and bursa disorder | MSKEL000057 | 3.29 | Musculoskeletal | Stromal / connective | 1 | 2 | 4 | 7 | |
| 2031 | Arginine metabolites | METAB000003 | 3.29 | Metabolites | B / plasma cell | 3 | 0 | 1 | 2 | |
| 2032 | SLAMF1 levels | PROLV001875 | 3.29 | Protein levels | B / plasma cell | 22 | 2 | 12 | 27 | |
| 2033 | CRELD2/NUCB2 ratio | PRORT000757 | 3.29 | Protein ratios | Epithelial | 38 | 1 | 6 | 15 | |
| 2034 | PPME1/PSMD9 ratio | PRORT001700 | 3.29 | Protein ratios | Hepatocyte | 3 | 3 | 13 | 27 | |
| 2035 | Diglycerides | LIPID000038 | 3.28 | Lipids | Hepatocyte | 32 | 1 | 5 | 16 | |
| 2036 | BTN2A1/IFNGR1 ratio | PRORT000256 | 3.28 | Protein ratios | Myeloid | 21 | 1 | 6 | 8 | |
| 2037 | PBLD levels | PROLV001500 | 3.28 | Protein levels | Muscle / cardiac | 5 | 6 | 18 | 62 | |
| 2038 | GALNT10/IGSF3 ratio | PRORT001201 | 3.28 | Protein ratios | Hepatocyte | 8 | 3 | 11 | 21 | |
| 2039 | CEACAM5 levels | PROLV000392 | 3.27 | Protein levels | Respiratory epithelium | 81 | 0 | 5 | 15 | |
| 2040 | Phosphatidylinositols | LIPID000061 | 3.27 | Lipids | Granulosa cell | 20 | 2 | 2 | 10 | |
| 2041 | GCNT1 levels | PROLV000868 | 3.26 | Protein levels | Myeloid | 33 | 0 | 4 | 12 | |
| 2042 | NOTCH1/TIE1 ratio | PRORT001592 | 3.26 | Protein ratios | Neural / glial | 13 | 3 | 9 | 15 | |
| 2043 | Cutaneous cysts and sinuses | DERMA000002 | 3.26 | Dermatologic | Cutaneous epithelium | 30 | 0 | 13 | 20 | |
| 2044 | HHIP levels | PROLV000969 | 3.26 | Protein levels | B / plasma cell | 0 | 3 | 9 | 16 | |
| 2045 | Gout | METBL000043 | 3.26 | Metabolic | Hepatocyte | 506 | 1 | 10 | 10 | |
| 2046 | TNFRSF11A levels | PROLV002060 | 3.25 | Protein levels | B / plasma cell | 31 | 1 | 4 | 8 | |
| 2047 | Insomnia | PSYCH000038 | 3.25 | Psychiatric | Neural / glial | 63 | 2 | 6 | 14 | |
| 2048 | PCSK9 levels | PROLV001512 | 3.25 | Protein levels | Hepatocyte | 87 | 1 | 5 | 8 | |
| 2049 | SH2B3 levels | PROLV001851 | 3.24 | Protein levels | Myeloid | 29 | 2 | 9 | 12 | |
| 2050 | IL6ST levels | PROLV001079 | 3.23 | Protein levels | Hepatocyte | 62 | 2 | 7 | 15 | |
| 2051 | GIMAP7 levels | PROLV000887 | 3.23 | Protein levels | Lymphocyte | 26 | 2 | 10 | 41 | |
| 2052 | LONP1 levels | PROLV001220 | 3.23 | Protein levels | Myeloid | 20 | 3 | 11 | 20 | |
| 2053 | Polycystic ovary syndrome | REPRO000024 | 3.22 | Reproductive | Granulosa cell | 29 | 2 | 4 | 19 | |
| 2054 | ENG levels | PROLV000704 | 3.22 | Protein levels | Adipose | 10 | 4 | 12 | 30 | |
| 2055 | PLXDC2 levels | PROLV001584 | 3.22 | Protein levels | Granulosa cell | 18 | 4 | 16 | 23 | |
| 2056 | CD101 levels | PROLV000308 | 3.21 | Protein levels | Lymphocyte | 57 | 2 | 17 | 43 | |
| 2057 | PSMD9/UBAC1 ratio | PRORT001712 | 3.21 | Protein ratios | Muscle / cardiac | 4 | 1 | 4 | 8 | |
| 2058 | MTSS2 levels | PROLV001350 | 3.20 | Protein levels | Myeloid | 27 | 2 | 5 | 9 | |
| 2059 | Smoking effects on COPD x smoking interaction | RESPI000013 | 3.20 | Respiratory | Hepatocyte | 21 | 0 | 4 | 7 | |
| 2060 | Intelligence | PSYCH000004 | 3.20 | Psychiatric | Neural / glial | 305 | 2 | 3 | 13 | |
| 2061 | CD36 levels | PROLV000337 | 3.19 | Protein levels | Myeloid | 112 | 2 | 5 | 9 | |
| 2062 | CLSTN3 levels | PROLV000465 | 3.19 | Protein levels | Hepatocyte | 53 | 1 | 5 | 15 | |
| 2063 | Cutaneous haemangioma | DERMA000003 | 3.18 | Dermatologic | Myeloid | 1 | 1 | 7 | 12 | |
| 2064 | EIF4G1/PLA2G4A ratio | PRORT001013 | 3.18 | Protein ratios | Vascular | 11 | 2 | 10 | 16 | |
| 2065 | MIA levels | PROLV001311 | 3.18 | Protein levels | Neural / glial | 91 | 4 | 7 | 14 | |
| 2066 | CCL2 levels | PROLV000286 | 3.18 | Protein levels | Myeloid | 106 | 3 | 6 | 7 | |
| 2067 | Erysipelas | IMMUN000062 | 3.17 | Immunologic | Hepatocyte | 19 | 2 | 6 | 19 | |
| 2068 | IL2RA/NCR1 ratio | PRORT001351 | 3.17 | Protein ratios | Lymphocyte | 29 | 3 | 8 | 38 | |
| 2069 | CALCOCO1/PFKFB2 ratio | PRORT000301 | 3.17 | Protein ratios | Myeloid | 1 | 5 | 10 | 23 | |
| 2070 | UGDH levels | PROLV002138 | 3.17 | Protein levels | B / plasma cell | 21 | 4 | 12 | 33 | |
| 2071 | NFU1 levels | PROLV001400 | 3.16 | Protein levels | Stromal / connective | 2 | 3 | 7 | 16 | |
| 2072 | CTSF/NAAA ratio | PRORT000801 | 3.16 | Protein ratios | Hepatocyte | 46 | 3 | 13 | 23 | |
| 2073 | TNR levels | PROLV002084 | 3.16 | Protein levels | Vascular | 90 | 3 | 8 | 15 | |
| 2074 | DNAJB1/STIP1 ratio | PRORT000930 | 3.15 | Protein ratios | Hepatocyte | 29 | 2 | 8 | 12 | |
| 2075 | ACVRL1/EFNA4 ratio | PRORT000014 | 3.15 | Protein ratios | Vascular | 35 | 4 | 10 | 14 | |
| 2076 | DKK1/PDGFA ratio | PRORT000898 | 3.15 | Protein ratios | Hematopoietic progenitor | 4 | 3 | 10 | 26 | |
| 2077 | PATE4 levels | PROLV001498 | 3.14 | Protein levels | Muscle / cardiac | 0 | 2 | 9 | 19 | |
| 2078 | TNFRSF1B levels | PROLV002069 | 3.14 | Protein levels | Lymphocyte | 74 | 1 | 7 | 21 | |
| 2079 | CD274 levels | PROLV000325 | 3.13 | Protein levels | Muscle / cardiac | 5 | 2 | 5 | 10 | |
| 2080 | PTPRK levels | PROLV001677 | 3.13 | Protein levels | Hepatocyte | 30 | 1 | 8 | 20 | |
| 2081 | EFNA4/VWC2 ratio | PRORT000993 | 3.13 | Protein ratios | Hepatocyte | 4 | 2 | 12 | 18 | |
| 2082 | PLA2G4A/SNX9 ratio | PRORT001676 | 3.12 | Protein ratios | Myeloid | 0 | 2 | 3 | 11 | |
| 2083 | SMOC2 levels | PROLV001900 | 3.12 | Protein levels | Stromal / connective | 4 | 0 | 1 | 2 | |
| 2084 | CCL28 levels | PROLV000295 | 3.12 | Protein levels | Myeloid | 61 | 2 | 8 | 17 | |
| 2085 | CD209/CLEC14A ratio | PRORT000395 | 3.12 | Protein ratios | B / plasma cell | 0 | 2 | 5 | 7 | |
| 2086 | DCTN1/ERBIN ratio | PRORT000871 | 3.11 | Protein ratios | Hepatocyte | 0 | 4 | 13 | 21 | |
| 2087 | CPXM1/DKK1 ratio | PRORT000732 | 3.11 | Protein ratios | Hematopoietic progenitor | 9 | 3 | 10 | 9 | |
| 2088 | VASH1 levels | PROLV002150 | 3.10 | Protein levels | Myeloid | 18 | 2 | 6 | 15 | |
| 2089 | PRSS53 levels | PROLV001647 | 3.09 | Protein levels | Hepatocyte | 56 | 2 | 9 | 25 | |
| 2090 | S100A12 levels | PROLV001767 | 3.09 | Protein levels | Lymphocyte | 6 | 3 | 14 | 39 | |
| 2091 | MTIF3 levels | PROLV001348 | 3.09 | Protein levels | Myeloid | 3 | 2 | 7 | 13 | |
| 2092 | MYBPC1 levels | PROLV001356 | 3.09 | Protein levels | Muscle / cardiac | 18 | 4 | 9 | 21 | |
| 2093 | DIABLO/GRAP2 ratio | PRORT000890 | 3.08 | Protein ratios | Muscle / cardiac | 1 | 3 | 10 | 20 | |
| 2094 | NUCB2/RSPO3 ratio | PRORT001606 | 3.08 | Protein ratios | Muscle / cardiac | 6 | 2 | 6 | 12 | |
| 2095 | Glycine metabolites | METAB000007 | 3.07 | Metabolites | Hepatocyte | 13 | 1 | 2 | 12 | |
| 2096 | HAVCR1 levels | PROLV000953 | 3.07 | Protein levels | Hepatocyte | 20 | 0 | 8 | 27 | |
| 2097 | Barrett's oesophagus | GASTR000046 | 3.07 | Gastrointestinal | Stromal / connective | 11 | 2 | 6 | 14 | |
| 2098 | ADAM23 levels | PROLV000028 | 3.06 | Protein levels | Granulosa cell | 35 | 1 | 4 | 4 | |
| 2099 | ABL1 levels | PROLV000006 | 3.06 | Protein levels | Vascular | 1 | 2 | 6 | 13 | |
| 2100 | RCC1 levels | PROLV001715 | 3.06 | Protein levels | B / plasma cell | 14 | 2 | 8 | 21 | |
| 2101 | Lipid unsaturation | LIPID000079 | 3.05 | Lipids | Lymphocyte | 10 | 1 | 13 | 40 | |
| 2102 | CDKN1A/FXN ratio | PRORT000568 | 3.05 | Protein ratios | Hepatocyte | 19 | 2 | 10 | 18 | |
| 2103 | Pain, limb | MSKEL000037 | 3.05 | Musculoskeletal | B / plasma cell | 1 | 5 | 10 | 20 | |
| 2104 | CD46/SIAE ratio | PRORT000459 | 3.05 | Protein ratios | Vascular | 13 | 2 | 8 | 19 | |
| 2105 | MMP8/TGFA ratio | PRORT001545 | 3.05 | Protein ratios | Myeloid | 0 | 1 | 8 | 8 | |
| 2106 | CTSV levels | PROLV000569 | 3.04 | Protein levels | Myeloid | 145 | 3 | 6 | 13 | |
| 2107 | ERBB4/NELL1 ratio | PRORT001047 | 3.04 | Protein ratios | Renal epithelium | 15 | 0 | 4 | 5 | |
| 2108 | CD302/IL12A_IL12B ratio | PRORT000438 | 3.03 | Protein ratios | B / plasma cell | 43 | 4 | 9 | 19 | |
| 2109 | LAP3 levels | PROLV001183 | 3.03 | Protein levels | Vascular | 8 | 2 | 6 | 12 | |
| 2110 | FGF5 levels | PROLV000797 | 3.03 | Protein levels | Hepatocyte | 31 | 3 | 5 | 10 | |
| 2111 | PENK levels | PROLV001535 | 3.03 | Protein levels | Myeloid | 19 | 1 | 4 | 11 | |
| 2112 | CRADD/EDAR ratio | PRORT000743 | 3.03 | Protein ratios | Myeloid | 37 | 4 | 5 | 13 | |
| 2113 | CNTN1/EGFR ratio | PRORT000685 | 3.03 | Protein ratios | Hepatocyte | 69 | 2 | 10 | 12 | |
| 2114 | ADAMTS15/CLMP ratio | PRORT000024 | 3.02 | Protein ratios | Hepatocyte | 35 | 1 | 10 | 13 | |
| 2115 | REG1A/TFF3 ratio | PRORT001731 | 3.02 | Protein ratios | Epithelial | 50 | 0 | 8 | 12 | |
| 2116 | CHGB levels | PROLV000427 | 3.01 | Protein levels | Neural / glial | 3 | 2 | 6 | 15 | |
| 2117 | SELE levels | PROLV001803 | 3.01 | Protein levels | Vascular | 55 | 2 | 4 | 14 | |
| 2118 | KLK13 levels | PROLV001153 | 3.01 | Protein levels | Myeloid | 106 | 2 | 10 | 12 | |
| 2119 | NUCB2 levels | PROLV001451 | 3.00 | Protein levels | Muscle / cardiac | 11 | 4 | 6 | 19 | |
| 2120 | TIMM10 levels | PROLV002036 | 3.00 | Protein levels | Stromal / connective | 21 | 2 | 6 | 11 | |
| 2121 | Taste preference | DTSUP000023 | 2.99 | Diet and Supplement | Neural / glial | 83 | 3 | 6 | 17 | |
| 2122 | ARHGEF1 levels | PROLV000139 | 2.99 | Protein levels | Myeloid | 5 | 2 | 5 | 9 | |
| 2123 | MATN2/SCARA5 ratio | PRORT001494 | 2.99 | Protein ratios | Stromal / connective | 12 | 5 | 9 | 19 | |
| 2124 | ENG/TNFRSF10C ratio | PRORT001020 | 2.99 | Protein ratios | Neural / glial | 1 | 1 | 6 | 8 | |
| 2125 | RARRES2/TFPI ratio | PRORT001728 | 2.98 | Protein ratios | Hepatocyte | 38 | 1 | 9 | 17 | |
| 2126 | CD40LG/MPIG6B ratio | PRORT000452 | 2.98 | Protein ratios | Myeloid | 0 | 4 | 12 | 17 | |
| 2127 | XCL1 levels | PROLV002196 | 2.98 | Protein levels | Myeloid | 70 | 2 | 9 | 18 | |
| 2128 | FYB1 levels | PROLV000842 | 2.97 | Protein levels | Myeloid | 34 | 2 | 6 | 17 | |
| 2129 | BIN2/TMSB10 ratio | PRORT000234 | 2.97 | Protein ratios | Myeloid | 0 | 3 | 9 | 19 | |
| 2130 | DLL1/EFEMP1 ratio | PRORT000914 | 2.97 | Protein ratios | Hepatocyte | 33 | 2 | 7 | 20 | |
| 2131 | Myasthenia gravis | IMMUN000035 | 2.96 | Immunologic | Lymphocyte | 54 | 1 | 13 | 36 | |
| 2132 | A1BG levels | PROLV000001 | 2.95 | Protein levels | Hepatocyte | 32 | 1 | 7 | 9 | |
| 2133 | PF4 levels | PROLV001538 | 2.94 | Protein levels | Myeloid | 34 | 4 | 9 | 18 | |
| 2134 | Osteopenia | MSKEL000009 | 2.93 | Musculoskeletal | Adipose | 0 | 2 | 10 | 35 | |
| 2135 | Allergic disease | IMMUN000003 | 2.93 | Immunologic | Lymphocyte | 228 | 2 | 12 | 17 | |
| 2136 | CLPS/PLA2G1B ratio | PRORT000674 | 2.93 | Protein ratios | Lymphocyte | 18 | 3 | 12 | 25 | |
| 2137 | Brain general volume | NIMAG000015 | 2.93 | Neuroimaging | Neural / glial | 5 | 2 | 6 | 15 | |
| 2138 | Otitis media | AUDIO000017 | 2.92 | Auditory | Myeloid | 33 | 0 | 2 | 4 | |
| 2139 | PLXNA4/USP8 ratio | PRORT001688 | 2.92 | Protein ratios | B / plasma cell | 5 | 4 | 8 | 32 | |
| 2140 | ABO levels | PROLV000007 | 2.92 | Protein levels | Muscle / cardiac | 5 | 1 | 6 | 10 | |
| 2141 | Hypothyroidism, congenital iodine deficiency | ENDOC000013 | 2.92 | Endocrine | Muscle / cardiac | 0 | 1 | 5 | 11 | |
| 2142 | CD46/TNFRSF14 ratio | PRORT000462 | 2.92 | Protein ratios | Vascular | 21 | 1 | 4 | 10 | |
| 2143 | CASP8/RILP ratio | PRORT000324 | 2.92 | Protein ratios | Hepatocyte | 2 | 3 | 8 | 19 | |
| 2144 | CHRDL2 levels | PROLV000434 | 2.92 | Protein levels | Adipose | 0 | 1 | 6 | 14 | |
| 2145 | NECTIN2/SDC1 ratio | PRORT001578 | 2.91 | Protein ratios | Hepatocyte | 59 | 1 | 11 | 9 | |
| 2146 | THBD levels | PROLV002025 | 2.91 | Protein levels | Vascular | 104 | 1 | 4 | 11 | |
| 2147 | PRTN3/RETN ratio | PRORT001711 | 2.91 | Protein ratios | Myeloid | 11 | 1 | 5 | 7 | |
| 2148 | BMP7 levels | PROLV000205 | 2.91 | Protein levels | Lymphocyte | 0 | 2 | 14 | 29 | |
| 2149 | SLMAP levels | PROLV001891 | 2.91 | Protein levels | Myeloid | 11 | 2 | 5 | 12 | |
| 2150 | IGFBP4/OGN ratio | PRORT001335 | 2.91 | Protein ratios | Stromal / connective | 0 | 2 | 11 | 29 | |
| 2151 | SFRP1 levels | PROLV001844 | 2.90 | Protein levels | Vascular | 20 | 3 | 6 | 17 | |
| 2152 | PRRT3 levels | PROLV001643 | 2.90 | Protein levels | Hepatocyte | 80 | 1 | 6 | 17 | |
| 2153 | LYPD3 levels | PROLV001252 | 2.89 | Protein levels | Epithelial | 159 | 2 | 5 | 7 | |
| 2154 | HBEGF/PDGFB ratio | PRORT001269 | 2.89 | Protein ratios | Myeloid | 32 | 1 | 5 | 14 | |
| 2155 | CSF3R levels | PROLV000541 | 2.89 | Protein levels | Myeloid | 76 | 1 | 4 | 10 | |
| 2156 | Abdominal and pelvic pain | GASTR000043 | 2.89 | Gastrointestinal | Neural / glial | 0 | 4 | 7 | 13 | |
| 2157 | LAT/MANF ratio | PRORT001423 | 2.88 | Protein ratios | Muscle / cardiac | 0 | 3 | 6 | 14 | |
| 2158 | Calcium | METAB000043 | 2.88 | Metabolites | Hepatocyte | 779 | 2 | 9 | 13 | |
| 2159 | Connective tissue disorder | MSKEL000060 | 2.88 | Musculoskeletal | Myeloid | 44 | 1 | 4 | 21 | |
| 2160 | Adhesive capsulitis | MSKEL000058 | 2.88 | Musculoskeletal | Stromal / connective | 26 | 1 | 5 | 13 | |
| 2161 | LBR levels | PROLV001189 | 2.88 | Protein levels | Lymphocyte | 6 | 5 | 12 | 47 | |
| 2162 | Nerve root and plexus disorder | NEURO000029 | 2.88 | Neurologic | Myeloid | 0 | 2 | 8 | 12 | |
| 2163 | Upper respiratory tract disease | RESPI000042 | 2.88 | Respiratory | Lymphocyte | 13 | 2 | 19 | 32 | |
| 2164 | MOG/RTBDN ratio | PRORT001552 | 2.87 | Protein ratios | Stromal / connective | 4 | 2 | 8 | 21 | |
| 2165 | TNFRSF14/TNFRSF1A ratio | PRORT001850 | 2.87 | Protein ratios | Hepatocyte | 3 | 3 | 11 | 27 | |
| 2166 | LIFR levels | PROLV001210 | 2.87 | Protein levels | Vascular | 75 | 4 | 12 | 46 | |
| 2167 | LY9 levels | PROLV001249 | 2.86 | Protein levels | Myeloid | 87 | 1 | 6 | 12 | |
| 2168 | DNMBP/WWP2 ratio | PRORT000934 | 2.86 | Protein ratios | Lymphocyte | 12 | 2 | 12 | 42 | |
| 2169 | CA3 levels | PROLV000244 | 2.86 | Protein levels | Muscle / cardiac | 7 | 3 | 8 | 23 | |
| 2170 | BIN2/FYB1 ratio | PRORT000232 | 2.86 | Protein ratios | Myeloid | 1 | 3 | 9 | 21 | |
| 2171 | MANF/TXNDC5 ratio | PRORT001482 | 2.85 | Protein ratios | Hepatocyte | 1 | 5 | 12 | 22 | |
| 2172 | Acylcarnitines | METAB000038 | 2.85 | Metabolites | Hepatocyte | 0 | 0 | 0 | 0 | |
| 2173 | AKT1S1/TDRKH ratio | PRORT000066 | 2.85 | Protein ratios | Stromal / connective | 0 | 3 | 9 | 28 | |
| 2174 | Low hand grip strength | MSKEL000032 | 2.85 | Musculoskeletal | Muscle / cardiac | 1 | 4 | 10 | 21 | |
| 2175 | MCFD2/VSIR ratio | PRORT001507 | 2.85 | Protein ratios | Muscle / cardiac | 30 | 1 | 4 | 13 | |
| 2176 | Placental weight | REPRO000026 | 2.84 | Reproductive | Hepatocyte | 59 | 3 | 8 | 17 | |
| 2177 | SCLY levels | PROLV001790 | 2.83 | Protein levels | Hepatocyte | 62 | 2 | 8 | 16 | |
| 2178 | LRIG3 levels | PROLV001228 | 2.83 | Protein levels | Lymphocyte | 0 | 0 | 9 | 20 | |
| 2179 | BDNF levels | PROLV000191 | 2.83 | Protein levels | Myeloid | 37 | 2 | 8 | 17 | |
| 2180 | VASN levels | PROLV002151 | 2.82 | Protein levels | Hepatocyte | 136 | 1 | 7 | 11 | |
| 2181 | NDUFB7 levels | PROLV001386 | 2.82 | Protein levels | Stromal / connective | 24 | 2 | 6 | 13 | |
| 2182 | SEPTIN3 levels | PROLV001813 | 2.82 | Protein levels | B / plasma cell | 64 | 3 | 5 | 25 | |
| 2183 | FAM3B/FGF19 ratio | PRORT001111 | 2.82 | Protein ratios | Hepatocyte | 18 | 2 | 7 | 14 | |
| 2184 | PRKAR1A/SNAP23 ratio | PRORT001710 | 2.82 | Protein ratios | Hepatocyte | 4 | 3 | 18 | 38 | |
| 2185 | Ornithine metabolites | METAB000011 | 2.82 | Metabolites | B / plasma cell | 0 | 2 | 9 | 9 | |
| 2186 | CDHR5 levels | PROLV000380 | 2.81 | Protein levels | Hepatocyte | 114 | 1 | 5 | 9 | |
| 2187 | GPRC5C levels | PROLV000930 | 2.81 | Protein levels | Hepatocyte | 102 | 1 | 6 | 11 | |
| 2188 | TNFSF12 levels | PROLV002077 | 2.81 | Protein levels | Lymphocyte | 61 | 2 | 7 | 31 | |
| 2189 | SDK2 levels | PROLV001800 | 2.80 | Protein levels | Myeloid | 29 | 3 | 14 | 24 | |
| 2190 | VTI1A levels | PROLV002178 | 2.80 | Protein levels | Myeloid | 10 | 2 | 9 | 20 | |
| 2191 | MAPK13 levels | PROLV001270 | 2.80 | Protein levels | Hepatocyte | 7 | 3 | 8 | 12 | |
| 2192 | SPINT1 levels | PROLV001932 | 2.79 | Protein levels | Cutaneous epithelium | 74 | 0 | 5 | 11 | |
| 2193 | DAAM1 levels | PROLV000590 | 2.79 | Protein levels | Myeloid | 41 | 1 | 4 | 19 | |
| 2194 | GYS1/TIA1 ratio | PRORT001256 | 2.79 | Protein ratios | Hepatocyte | 13 | 3 | 12 | 19 | |
| 2195 | MED18/TBL1X ratio | PRORT001511 | 2.79 | Protein ratios | Myeloid | 35 | 3 | 11 | 22 | |
| 2196 | GC levels | PROLV000864 | 2.79 | Protein levels | Myeloid | 15 | 2 | 7 | 19 | |
| 2197 | Fracture | MSKEL000011 | 2.79 | Musculoskeletal | Stromal / connective | 27 | 1 | 1 | 1 | |
| 2198 | Heme malignancy, Plasma cell | MALIG000046 | 2.79 | Malignancy | B / plasma cell | 3 | 2 | 14 | 35 | |
| 2199 | ERBB3/IL1R2 ratio | PRORT001045 | 2.78 | Protein ratios | Hepatocyte | 47 | 2 | 8 | 18 | |
| 2200 | AXIN1/HEXIM1 ratio | PRORT000170 | 2.78 | Protein ratios | Stromal / connective | 1 | 3 | 10 | 23 | |
| 2201 | MMP1 levels | PROLV001321 | 2.78 | Protein levels | Hematopoietic progenitor | 57 | 6 | 11 | 19 | |
| 2202 | GPR37 levels | PROLV000929 | 2.78 | Protein levels | Hepatocyte | 88 | 2 | 9 | 21 | |
| 2203 | NECTIN4/SPINK5 ratio | PRORT001583 | 2.78 | Protein ratios | Myeloid | 11 | 0 | 7 | 11 | |
| 2204 | Skin and soft tissue infection | IMMUN000073 | 2.78 | Immunologic | B / plasma cell | 9 | 1 | 8 | 22 | |
| 2205 | SELPLG levels | PROLV001806 | 2.78 | Protein levels | Myeloid | 68 | 2 | 11 | 35 | |
| 2206 | MNDA/NCF2 ratio | PRORT001550 | 2.78 | Protein ratios | Myeloid | 13 | 2 | 5 | 6 | |
| 2207 | PSIP1 levels | PROLV001657 | 2.77 | Protein levels | Muscle / cardiac | 10 | 2 | 10 | 35 | |
| 2208 | CPXM1 levels | PROLV000511 | 2.77 | Protein levels | Myeloid | 120 | 2 | 7 | 11 | |
| 2209 | FLT4/KDR ratio | PRORT001167 | 2.77 | Protein ratios | Vascular | 28 | 1 | 7 | 21 | |
| 2210 | FUT8/TNFSF14 ratio | PRORT001192 | 2.77 | Protein ratios | Adipose | 13 | 4 | 22 | 56 | |
| 2211 | CDC37/SNX9 ratio | PRORT000542 | 2.76 | Protein ratios | Vascular | 1 | 3 | 7 | 24 | |
| 2212 | ATP5IF1 levels | PROLV000161 | 2.76 | Protein levels | Myeloid | 43 | 2 | 5 | 14 | |
| 2213 | LRRFIP1 levels | PROLV001235 | 2.76 | Protein levels | Vascular | 39 | 2 | 6 | 23 | |
| 2214 | CCN3/COL6A3 ratio | PRORT000372 | 2.76 | Protein ratios | Stromal / connective | 26 | 0 | 3 | 5 | |
| 2215 | PRSS27 levels | PROLV001646 | 2.76 | Protein levels | Myeloid | 51 | 1 | 5 | 10 | |
| 2216 | RTN4IP1 levels | PROLV001761 | 2.76 | Protein levels | Myeloid | 2 | 2 | 5 | 11 | |
| 2217 | CXCL9 levels | PROLV000587 | 2.76 | Protein levels | Lymphocyte | 72 | 2 | 13 | 32 | |
| 2218 | ITGB5 levels | PROLV001114 | 2.75 | Protein levels | Platelet | 18 | 2 | 5 | 10 | |
| 2219 | TACC3 levels | PROLV001988 | 2.75 | Protein levels | Myeloid | 46 | 1 | 4 | 13 | |
| 2220 | ANXA3/EDAR ratio | PRORT000105 | 2.75 | Protein ratios | Myeloid | 22 | 1 | 3 | 6 | |
| 2221 | CXCL5/PLXNA4 ratio | PRORT000829 | 2.75 | Protein ratios | Myeloid | 0 | 5 | 14 | 31 | |
| 2222 | ASS1 levels | PROLV000156 | 2.74 | Protein levels | Hepatocyte | 31 | 2 | 11 | 15 | |
| 2223 | CKAP4/TNFRSF4 ratio | PRORT000624 | 2.74 | Protein ratios | Hepatocyte | 21 | 2 | 10 | 35 | |
| 2224 | TFRC levels | PROLV002017 | 2.74 | Protein levels | Myeloid | 70 | 3 | 7 | 24 | |
| 2225 | FADD/NCK2 ratio | PRORT001106 | 2.74 | Protein ratios | Neural / glial | 6 | 3 | 8 | 14 | |
| 2226 | BMP4 levels | PROLV000203 | 2.73 | Protein levels | Granulosa cell | 46 | 2 | 8 | 26 | |
| 2227 | Triglycerides | LIPID000039 | 2.73 | Lipids | Hepatocyte | 33 | 1 | 3 | 13 | |
| 2228 | CLMP/PIK3IP1 ratio | PRORT000669 | 2.73 | Protein ratios | Adipose | 1 | 3 | 6 | 10 | |
| 2229 | PFDN5 levels | PROLV001539 | 2.72 | Protein levels | Muscle / cardiac | 0 | 4 | 9 | 24 | |
| 2230 | Substance use | PSYCH000049 | 2.72 | Psychiatric | Muscle / cardiac | 0 | 4 | 6 | 14 | |
| 2231 | CALCB levels | PROLV000256 | 2.72 | Protein levels | Myeloid | 1 | 0 | 3 | 2 | |
| 2232 | CFD levels | PROLV000412 | 2.72 | Protein levels | Myeloid | 9 | 0 | 6 | 14 | |
| 2233 | GRAP2/TYMP ratio | PRORT001247 | 2.72 | Protein ratios | Hepatocyte | 7 | 4 | 11 | 25 | |
| 2234 | PON1 levels | PROLV001600 | 2.71 | Protein levels | Granulosa cell | 40 | 5 | 14 | 21 | |
| 2235 | RILP levels | PROLV001734 | 2.71 | Protein levels | Lymphocyte | 22 | 2 | 15 | 42 | |
| 2236 | MCAM levels | PROLV001283 | 2.71 | Protein levels | Granulosa cell | 164 | 2 | 6 | 15 | |
| 2237 | Exophthalmic conditions | OPHTH000018 | 2.70 | Ophthalmic | Adipose | — | 2 | 9 | 12 | |
| 2238 | DNM3 levels | PROLV000639 | 2.70 | Protein levels | Hematopoietic progenitor | 17 | 1 | 2 | 10 | |
| 2239 | BACH1 levels | PROLV000173 | 2.70 | Protein levels | Myeloid | 10 | 2 | 7 | 12 | |
| 2240 | ADH4/KRT18 ratio | PRORT000040 | 2.70 | Protein ratios | Hepatocyte | 12 | 1 | 11 | 17 | |
| 2241 | GPC1/ITGB6 ratio | PRORT001238 | 2.69 | Protein ratios | Muscle / cardiac | 32 | 3 | 9 | 11 | |
| 2242 | GP2/LGALS8 ratio | PRORT001230 | 2.69 | Protein ratios | Epithelial | 14 | 1 | 4 | 11 | |
| 2243 | ADGRG2/ITGB1 ratio | PRORT000035 | 2.69 | Protein ratios | Granulosa cell | 1 | 1 | 7 | 8 | |
| 2244 | TMSB10 levels | PROLV002051 | 2.69 | Protein levels | Myeloid | 12 | 3 | 7 | 18 | |
| 2245 | SIRPA levels | PROLV001867 | 2.69 | Protein levels | Granulosa cell | 24 | 2 | 9 | 10 | |
| 2246 | MMP7 levels | PROLV001326 | 2.69 | Protein levels | Hepatocyte | 5 | 1 | 11 | 22 | |
| 2247 | RNF146 levels | PROLV001744 | 2.68 | Protein levels | Muscle / cardiac | 0 | 1 | 3 | 18 | |
| 2248 | CCL26 levels | PROLV000293 | 2.68 | Protein levels | Lymphocyte | 64 | 3 | 8 | 16 | |
| 2249 | EDAR/ENO2 ratio | PRORT000966 | 2.68 | Protein ratios | Myeloid | 31 | 4 | 7 | 19 | |
| 2250 | SYTL4 levels | PROLV001986 | 2.68 | Protein levels | Myeloid | 17 | 3 | 7 | 18 | |
| 2251 | INHBC levels | PROLV001088 | 2.68 | Protein levels | Hepatocyte | 91 | 2 | 8 | 18 | |
| 2252 | IGFBP7 levels | PROLV001033 | 2.68 | Protein levels | Hepatocyte | 24 | 1 | 7 | 17 | |
| 2253 | TOP1 levels | PROLV002087 | 2.67 | Protein levels | Hepatocyte | 36 | 3 | 12 | 18 | |
| 2254 | IRAK4/VASH1 ratio | PRORT001370 | 2.67 | Protein ratios | Muscle / cardiac | 0 | 2 | 5 | 16 | |
| 2255 | WWP2 levels | PROLV002195 | 2.66 | Protein levels | Myeloid | 20 | 2 | 8 | 11 | |
| 2256 | Seborrhoeic dermatitis | DERMA000020 | 2.66 | Dermatologic | Lymphocyte | 98 | 2 | 16 | 19 | |
| 2257 | DIABLO/PRKAR1A ratio | PRORT000893 | 2.66 | Protein ratios | Myeloid | 12 | 3 | 12 | 18 | |
| 2258 | CCL5/TFPI ratio | PRORT000360 | 2.66 | Protein ratios | Myeloid | 7 | 1 | 4 | 16 | |
| 2259 | CAPN3 levels | PROLV000263 | 2.66 | Protein levels | B / plasma cell | 0 | 2 | 9 | 11 | |
| 2260 | ENDOU levels | PROLV000703 | 2.66 | Protein levels | Cutaneous epithelium | 77 | 2 | 12 | 12 | |
| 2261 | PAK4 levels | PROLV001488 | 2.66 | Protein levels | Myeloid | 1 | 3 | 8 | 16 | |
| 2262 | TNF levels | PROLV002053 | 2.66 | Protein levels | Lymphocyte | 30 | 2 | 10 | 20 | |
| 2263 | PGLS levels | PROLV001545 | 2.65 | Protein levels | Neural / glial | 0 | 5 | 6 | 27 | |
| 2264 | LTA levels | PROLV001239 | 2.65 | Protein levels | Lymphocyte | 112 | 3 | 17 | 32 | |
| 2265 | EDAR/YES1 ratio | PRORT000985 | 2.65 | Protein ratios | Myeloid | 30 | 5 | 12 | 27 | |
| 2266 | CCL21 levels | PROLV000288 | 2.65 | Protein levels | Lymphocyte | 35 | 1 | 4 | 11 | |
| 2267 | TNFRSF13B levels | PROLV002063 | 2.65 | Protein levels | B / plasma cell | 55 | 2 | 8 | 14 | |
| 2268 | APBB1IP/POLR2F ratio | PRORT000115 | 2.64 | Protein ratios | Myeloid | 11 | 3 | 20 | 34 | |
| 2269 | NID2 levels | PROLV001405 | 2.64 | Protein levels | Myeloid | 59 | 2 | 7 | 15 | |
| 2270 | SNCG levels | PROLV001909 | 2.64 | Protein levels | Muscle / cardiac | 11 | 2 | 5 | 11 | |
| 2271 | Sphingomyelins | LIPID000072 | 2.64 | Lipids | Hepatocyte | 272 | 1 | 2 | 8 | |
| 2272 | MAP2K1 levels | PROLV001266 | 2.64 | Protein levels | Lymphocyte | 23 | 3 | 11 | 34 | |
| 2273 | Tinnitus | AUDIO000014 | 2.63 | Auditory | Neural / glial | 2 | 4 | 8 | 12 | |
| 2274 | Pain, generic | MSKEL000035 | 2.63 | Musculoskeletal | Neural / glial | 4 | 4 | 17 | 25 | |
| 2275 | Household size | SOCIO000011 | 2.63 | Socioeconomic | Neural / glial | 0 | 4 | 9 | 17 | |
| 2276 | Maximal oxygen uptake | CARDI000026 | 2.63 | Cardiac | B / plasma cell | 1 | 4 | 12 | 22 | |
| 2277 | SELL levels | PROLV001804 | 2.62 | Protein levels | Myeloid | 28 | 4 | 9 | 16 | |
| 2278 | DEFA1 or DEFA1B levels | PROLV000613 | 2.62 | Protein levels | Myeloid | 56 | 1 | 6 | 5 | |
| 2279 | ANGPT1/SERPINE1 ratio | PRORT000098 | 2.62 | Protein ratios | Platelet | 21 | 1 | 4 | 8 | |
| 2280 | Snack and fast-food preference | DTSUP000017 | 2.62 | Diet and Supplement | Neural / glial | 36 | 4 | 7 | 24 | |
| 2281 | Cardiac conduction disorder | CARDI000030 | 2.62 | Cardiac | Muscle / cardiac | 14 | 3 | 6 | 13 | |
| 2282 | LY6D/WFDC12 ratio | PRORT001470 | 2.61 | Protein ratios | Myeloid | 14 | 2 | 17 | 20 | |
| 2283 | NFATC1 levels | PROLV001395 | 2.61 | Protein levels | Myeloid | 34 | 2 | 6 | 12 | |
| 2284 | CALCOCO1/TJAP1 ratio | PRORT000303 | 2.60 | Protein ratios | Muscle / cardiac | 0 | 4 | 14 | 32 | |
| 2285 | POLR2F levels | PROLV001598 | 2.60 | Protein levels | Muscle / cardiac | 1 | 4 | 8 | 22 | |
| 2286 | BLMH/SERPINE1 ratio | PRORT000237 | 2.59 | Protein ratios | Myeloid | 17 | 2 | 16 | 22 | |
| 2287 | EIF4G1/FOXO1 ratio | PRORT001009 | 2.59 | Protein ratios | Lymphocyte | 0 | 2 | 7 | 26 | |
| 2288 | AZU1/MPO ratio | PRORT000185 | 2.59 | Protein ratios | Myeloid | 8 | 1 | 4 | 8 | |
| 2289 | TNFRSF13B/TNFRSF9 ratio | PRORT001847 | 2.59 | Protein ratios | B / plasma cell | 19 | 2 | 14 | 28 | |
| 2290 | CLEC1B/NSFL1C ratio | PRORT000645 | 2.59 | Protein ratios | Myeloid | 9 | 3 | 8 | 16 | |
| 2291 | CD46 levels | PROLV000342 | 2.59 | Protein levels | Vascular | 58 | 2 | 8 | 12 | |
| 2292 | AXL/IL18BP ratio | PRORT000180 | 2.58 | Protein ratios | Neural / glial | 26 | 2 | 10 | 15 | |
| 2293 | Chronic respiratory disease | RESPI000003 | 2.58 | Respiratory | Lymphocyte | 99 | — | — | — | |
| 2294 | PCDH17/PTPRM ratio | PRORT001624 | 2.57 | Protein ratios | Vascular | 0 | 3 | 9 | 17 | |
| 2295 | EDAR/F2R ratio | PRORT000969 | 2.57 | Protein ratios | Platelet | 43 | 3 | 13 | 27 | |
| 2296 | TACC3/TRIAP1 ratio | PRORT001825 | 2.57 | Protein ratios | Myeloid | 1 | 3 | 5 | 7 | |
| 2297 | FIS1 levels | PROLV000806 | 2.57 | Protein levels | Myeloid | 54 | 3 | 8 | 20 | |
| 2298 | ANGPTL7 levels | PROLV000099 | 2.56 | Protein levels | Stromal / connective | 32 | 2 | 9 | 13 | |
| 2299 | PTPN1/SCAMP3 ratio | PRORT001716 | 2.56 | Protein ratios | Vascular | 11 | 3 | 9 | 14 | |
| 2300 | Brain MRI signal intensity | NIMAG000003 | 2.56 | Neuroimaging | Neural / glial | 143 | 4 | 7 | 15 | |
| 2301 | MECR levels | PROLV001291 | 2.55 | Protein levels | Stromal / connective | 13 | 4 | 8 | 13 | |
| 2302 | DSG2 levels | PROLV000655 | 2.55 | Protein levels | Epithelial | 31 | 0 | 9 | 6 | |
| 2303 | BST1 levels | PROLV000215 | 2.55 | Protein levels | Myeloid | 31 | 1 | 5 | 7 | |
| 2304 | CD6 levels | PROLV000349 | 2.54 | Protein levels | Lymphocyte | 89 | 2 | 19 | 32 | |
| 2305 | Hypothyroxinemia | ENDOC000022 | 2.54 | Endocrine | Neural / glial | 0 | 3 | 11 | 16 | |
| 2306 | MCFD2 levels | PROLV001286 | 2.54 | Protein levels | Myeloid | 10 | 3 | 7 | 10 | |
| 2307 | HYOU1/TGFBR3 ratio | PRORT001317 | 2.54 | Protein ratios | Hepatocyte | 27 | 2 | 8 | 23 | |
| 2308 | GLO1 levels | PROLV000895 | 2.54 | Protein levels | Lymphocyte | 0 | 2 | 7 | 31 | |
| 2309 | SNAP23/TXLNA ratio | PRORT001795 | 2.53 | Protein ratios | Hepatocyte | 0 | 2 | 12 | 24 | |
| 2310 | CDH17/SPINT1 ratio | PRORT000551 | 2.53 | Protein ratios | Lymphocyte | 11 | 1 | 12 | 15 | |
| 2311 | CRADD/SIRT2 ratio | PRORT000749 | 2.53 | Protein ratios | Hepatocyte | 16 | 1 | 9 | 19 | |
| 2312 | Gut microbial abundance, Olsenella C | GASTR000030 | 2.53 | Gastrointestinal | Vascular | 0 | 4 | 10 | 24 | |
| 2313 | Healthcare cost | SOCIO000025 | 2.53 | Socioeconomic | Neural / glial | 27 | 3 | 8 | 12 | |
| 2314 | GFRA1/SPON2 ratio | PRORT001208 | 2.52 | Protein ratios | Hepatocyte | 3 | 1 | 6 | 11 | |
| 2315 | CLSTN2/MATN2 ratio | PRORT000676 | 2.52 | Protein ratios | Hepatocyte | 25 | 2 | 8 | 16 | |
| 2316 | APOB levels | PROLV000120 | 2.51 | Protein levels | Hepatocyte | 618 | 1 | 7 | 9 | |
| 2317 | MILR1 levels | PROLV001314 | 2.51 | Protein levels | Hepatocyte | 64 | 2 | 5 | 19 | |
| 2318 | DOK2/PPP1R12A ratio | PRORT000941 | 2.51 | Protein ratios | Hepatocyte | 9 | 4 | 11 | 17 | |
| 2319 | CDH17/PECAM1 ratio | PRORT000549 | 2.51 | Protein ratios | Myeloid | 16 | 1 | 11 | 17 | |
| 2320 | IPCEF1/TBCB ratio | PRORT001364 | 2.51 | Protein ratios | Stromal / connective | 2 | 3 | 5 | 5 | |
| 2321 | TNN levels | PROLV002083 | 2.50 | Protein levels | Stromal / connective | 16 | 2 | 9 | 11 | |
| 2322 | TBL1X levels | PROLV002001 | 2.50 | Protein levels | Myeloid | 45 | 4 | 6 | 16 | |
| 2323 | CANT1/VSIR ratio | PRORT000310 | 2.50 | Protein ratios | Vascular | 15 | 1 | 5 | 12 | |
| 2324 | NRAC levels | PROLV001431 | 2.50 | Protein levels | Myeloid | 0 | 2 | 5 | 13 | |
| 2325 | PCYT2 levels | PROLV001513 | 2.50 | Protein levels | Myeloid | 4 | 3 | 8 | 16 | |
| 2326 | COL6A3/CST3 ratio | PRORT000696 | 2.50 | Protein ratios | Adipose | 33 | 3 | 8 | 18 | |
| 2327 | Lipoprotein particles, IDL | LIPID000044 | 2.48 | Lipids | Hepatocyte | 254 | 1 | 6 | 14 | |
| 2328 | Vegetable preference | DTSUP000020 | 2.47 | Diet and Supplement | Neural / glial | 91 | 3 | 8 | 18 | |
| 2329 | MB levels | PROLV001281 | 2.47 | Protein levels | Muscle / cardiac | 26 | 3 | 4 | 11 | |
| 2330 | Sinusitis | RESPI000039 | 2.46 | Respiratory | Lymphocyte | 11 | 2 | 13 | 30 | |
| 2331 | Medication, anti-diabetic | METBL000024 | 2.45 | Metabolic | Hematopoietic progenitor | 156 | 1 | 3 | 7 | |
| 2332 | ITGA6 levels | PROLV001107 | 2.45 | Protein levels | Myeloid | 24 | 2 | 6 | 15 | |
| 2333 | CD5/TNFRSF9 ratio | PRORT000468 | 2.45 | Protein ratios | Lymphocyte | 46 | 2 | 16 | 41 | |
| 2334 | PTH levels | PROLV001667 | 2.45 | Protein levels | Hepatocyte | 66 | 1 | 8 | 13 | |
| 2335 | F2R/TNFRSF14 ratio | PRORT001085 | 2.45 | Protein ratios | Lymphocyte | 15 | 3 | 9 | 34 | |
| 2336 | LRRC59 levels | PROLV001234 | 2.45 | Protein levels | Myeloid | 5 | 3 | 6 | 12 | |
| 2337 | PNMA1 levels | PROLV001594 | 2.43 | Protein levels | Myeloid | 18 | 4 | 10 | 17 | |
| 2338 | Branched-chain amino acid metabolites | METAB000004 | 2.43 | Metabolites | Lymphocyte | 0 | 1 | 8 | 31 | |
| 2339 | MAVS/MYO9B ratio | PRORT001496 | 2.43 | Protein ratios | Myeloid | 0 | 1 | 4 | 16 | |
| 2340 | Amygdala volume | NIMAG000014 | 2.43 | Neuroimaging | Hepatocyte | 32 | 0 | 1 | 7 | |
| 2341 | ITGB1BP2/MITD1 ratio | PRORT001385 | 2.43 | Protein ratios | Myeloid | 20 | 5 | 13 | 19 | |
| 2342 | TIE1 levels | PROLV002033 | 2.43 | Protein levels | Granulosa cell | 77 | 3 | 9 | 20 | |
| 2343 | SLC9A3R2 levels | PROLV001886 | 2.42 | Protein levels | Vascular | 16 | 2 | 7 | 14 | |
| 2344 | CD58/MEGF10 ratio | PRORT000477 | 2.42 | Protein ratios | Muscle / cardiac | 15 | 5 | 19 | 37 | |
| 2345 | DIABLO levels | PROLV000618 | 2.41 | Protein levels | Platelet | 35 | 1 | 5 | 12 | |
| 2346 | ERBB2 levels | PROLV000724 | 2.40 | Protein levels | Hepatocyte | 97 | 1 | 8 | 17 | |
| 2347 | CD58/LTBR ratio | PRORT000475 | 2.40 | Protein ratios | Epithelial | 25 | 0 | 6 | 14 | |
| 2348 | ATP5IF1/METAP1D ratio | PRORT000160 | 2.40 | Protein ratios | Myeloid | 6 | 3 | 9 | 28 | |
| 2349 | Systemic lupus erythematosus, SLE | IMMUN000020 | 2.39 | Immunologic | B / plasma cell | 93 | 2 | 4 | 19 | |
| 2350 | RLN2 levels | PROLV001736 | 2.39 | Protein levels | Muscle / cardiac | 6 | 4 | 10 | 24 | |
| 2351 | JCHAIN levels | PROLV001126 | 2.39 | Protein levels | B / plasma cell | 124 | 3 | 13 | 34 | |
| 2352 | Lysophosphatidylethanolamines | LIPID000055 | 2.39 | Lipids | Hepatocyte | 10 | 1 | 3 | 18 | |
| 2353 | RNF5 levels | PROLV001748 | 2.38 | Protein levels | Myeloid | 29 | 1 | 4 | 9 | |
| 2354 | Medication, Crohn disease | IMMUN000081 | 2.38 | Immunologic | Lymphocyte | 132 | 2 | 17 | 10 | |
| 2355 | EDAR/EGF ratio | PRORT000965 | 2.38 | Protein ratios | Lymphocyte | 3 | 4 | 12 | 35 | |
| 2356 | C3 levels | PROLV000232 | 2.38 | Protein levels | Myeloid | 55 | 2 | 6 | 14 | |
| 2357 | TDRKH levels | PROLV002008 | 2.38 | Protein levels | Vascular | 14 | 4 | 6 | 16 | |
| 2358 | Sexually transmitted infection | IMMUN000072 | 2.37 | Immunologic | Granulosa cell | 7 | 4 | 9 | 30 | |
| 2359 | LMOD1 levels | PROLV001219 | 2.37 | Protein levels | Myeloid | 10 | 2 | 7 | 11 | |
| 2360 | BCAM/CLEC14A ratio | PRORT000207 | 2.37 | Protein ratios | Vascular | 26 | 1 | 12 | 8 | |
| 2361 | CD177 levels | PROLV000314 | 2.37 | Protein levels | Myeloid | 21 | 1 | 6 | 7 | |
| 2362 | CD109 levels | PROLV000309 | 2.36 | Protein levels | Neural / glial | 31 | 4 | 14 | 36 | |
| 2363 | SDC4/SELP ratio | PRORT001765 | 2.36 | Protein ratios | Myeloid | 26 | 1 | 6 | 8 | |
| 2364 | CA1/HMBS ratio | PRORT000269 | 2.36 | Protein ratios | Lymphocyte | 14 | 4 | 20 | 40 | |
| 2365 | CD28 levels | PROLV000327 | 2.36 | Protein levels | B / plasma cell | 26 | 1 | 10 | 17 | |
| 2366 | FKBP4/SIRT2 ratio | PRORT001155 | 2.36 | Protein ratios | Hepatocyte | 34 | 1 | 9 | 17 | |
| 2367 | C1RL levels | PROLV000228 | 2.36 | Protein levels | Hepatocyte | 59 | 2 | 7 | 10 | |
| 2368 | TNFRSF13C levels | PROLV002064 | 2.35 | Protein levels | B / plasma cell | 45 | 3 | 7 | 22 | |
| 2369 | ESR1 levels | PROLV000735 | 2.35 | Protein levels | Adipose | 0 | 3 | 13 | 27 | |
| 2370 | DLK1 levels | PROLV000625 | 2.35 | Protein levels | Muscle / cardiac | 29 | 4 | 9 | 25 | |
| 2371 | EDAR/PRDX5 ratio | PRORT000974 | 2.35 | Protein ratios | Myeloid | 42 | 2 | 10 | 16 | |
| 2372 | CALCOCO1/CRACR2A ratio | PRORT000293 | 2.35 | Protein ratios | Muscle / cardiac | 0 | 1 | 19 | 32 | |
| 2373 | DNAJA2/SCAMP3 ratio | PRORT000925 | 2.35 | Protein ratios | Hepatocyte | 8 | 4 | 8 | 17 | |
| 2374 | Physical activity | BEHAV000007 | 2.35 | Behavioural | Neural / glial | 105 | 3 | 7 | 24 | |
| 2375 | LEG1 levels | PROLV001198 | 2.35 | Protein levels | Salivary epithelium | 43 | 1 | 3 | 3 | |
| 2376 | Chronic viral hepatitis | IMMUN000056 | 2.35 | Immunologic | Stromal / connective | 4 | 0 | 1 | 7 | |
| 2377 | IGFBP3 levels | PROLV001030 | 2.35 | Protein levels | Hepatocyte | 67 | 2 | 10 | 17 | |
| 2378 | TPSAB1 levels | PROLV002099 | 2.34 | Protein levels | Lymphocyte | 33 | 2 | 14 | 25 | |
| 2379 | REG1B levels | PROLV001718 | 2.34 | Protein levels | Pancreatic epithelium | 12 | 0 | 7 | 6 | |
| 2380 | PLXNA4 levels | PROLV001585 | 2.34 | Protein levels | Lymphocyte | 41 | 2 | 5 | 19 | |
| 2381 | Neuroticism | PSYCH000034 | 2.34 | Psychiatric | Neural / glial | 77 | 3 | 6 | 12 | |
| 2382 | Fruit preference | DTSUP000012 | 2.34 | Diet and Supplement | Neural / glial | 59 | 4 | 8 | 19 | |
| 2383 | PPIF levels | PROLV001608 | 2.33 | Protein levels | Myeloid | 3 | 2 | 9 | 19 | |
| 2384 | IL5RA levels | PROLV001076 | 2.33 | Protein levels | B / plasma cell | 181 | 3 | 12 | 28 | |
| 2385 | ARHGEF12/IRAK4 ratio | PRORT000141 | 2.33 | Protein ratios | Stromal / connective | 0 | 4 | 9 | 23 | |
| 2386 | Biventricular shape | CARDI000010 | 2.33 | Cardiac | Muscle / cardiac | 44 | 2 | 4 | 12 | |
| 2387 | AGRP/NPY ratio | PRORT000050 | 2.33 | Protein ratios | Hepatocyte | 28 | 1 | 9 | 10 | |
| 2388 | CD70 levels | PROLV000353 | 2.33 | Protein levels | Muscle / cardiac | 6 | 3 | 11 | 20 | |
| 2389 | AKT1S1/FHIT ratio | PRORT000064 | 2.33 | Protein ratios | Lymphocyte | 0 | 3 | 11 | 34 | |
| 2390 | Total lipids, IDL | LIPID000075 | 2.33 | Lipids | Hepatocyte | 281 | 1 | 7 | 12 | |
| 2391 | Thyroxine | ENDOC000025 | 2.32 | Endocrine | Hepatocyte | 14 | 1 | 5 | 13 | |
| 2392 | JAM2/TNFRSF21 ratio | PRORT001401 | 2.32 | Protein ratios | Vascular | 4 | 1 | 6 | 7 | |
| 2393 | Brain neuroimaging quality metric | NIMAG000006 | 2.32 | Neuroimaging | Muscle / cardiac | 29 | 1 | 2 | 6 | |
| 2394 | CACNA2D3 levels | PROLV000250 | 2.32 | Protein levels | B / plasma cell | 0 | 3 | 7 | 19 | |
| 2395 | THOP1 levels | PROLV002028 | 2.32 | Protein levels | Muscle / cardiac | 14 | 5 | 6 | 13 | |
| 2396 | SNX15 levels | PROLV001911 | 2.31 | Protein levels | Lymphocyte | 12 | 5 | 20 | 50 | |
| 2397 | HPSE levels | PROLV000986 | 2.31 | Protein levels | Lymphocyte | 29 | 3 | 8 | 20 | |
| 2398 | TIMP1 levels | PROLV002038 | 2.31 | Protein levels | Myeloid | 20 | 2 | 9 | 12 | |
| 2399 | Muscle fat infiltration | BCOMP000011 | 2.31 | Body composition | Myeloid | 40 | 2 | 8 | 20 | |
| 2400 | FUT8/PDGFA ratio | PRORT001187 | 2.30 | Protein ratios | Hepatocyte | 8 | 2 | 15 | 50 | |
| 2401 | TIA1 levels | PROLV002032 | 2.29 | Protein levels | Myeloid | 24 | 2 | 4 | 14 | |
| 2402 | CSNK2A1 levels | PROLV000544 | 2.29 | Protein levels | Myeloid | 22 | 1 | 9 | 11 | |
| 2403 | HMBS/PKLR ratio | PRORT001288 | 2.29 | Protein ratios | Lymphocyte | 29 | 1 | 15 | 23 | |
| 2404 | Cancer, Lung | MALIG000019 | 2.29 | Malignancy | Lymphocyte | 41 | 0 | 1 | 3 | |
| 2405 | S100A4 levels | PROLV001771 | 2.29 | Protein levels | Platelet | 18 | 3 | 7 | 14 | |
| 2406 | CRKL/FIS1 ratio | PRORT000763 | 2.29 | Protein ratios | Hepatocyte | 1 | 1 | 12 | 15 | |
| 2407 | Depression or anxiety | PSYCH000025 | 2.28 | Psychiatric | Neural / glial | 52 | 4 | 9 | 10 | |
| 2408 | Dyslipidaemia | METBL000020 | 2.28 | Metabolic | Hepatocyte | 416 | 1 | 6 | 10 | |
| 2409 | CLPS/PRSS2 ratio | PRORT000675 | 2.27 | Protein ratios | Hepatocyte | 25 | 1 | 5 | 8 | |
| 2410 | Testosterone | ENDOC000010 | 2.27 | Endocrine | Hepatocyte | 939 | 2 | 6 | 23 | |
| 2411 | SUGT1 levels | PROLV001972 | 2.26 | Protein levels | Myeloid | 38 | 3 | 9 | 14 | |
| 2412 | APOH levels | PROLV000126 | 2.26 | Protein levels | Hepatocyte | 2 | 2 | 10 | 17 | |
| 2413 | CD69/PLXNB3 ratio | PRORT000495 | 2.25 | Protein ratios | Myeloid | 0 | 3 | 8 | 16 | |
| 2414 | CPXM1/HBEGF ratio | PRORT000733 | 2.25 | Protein ratios | Myeloid | 44 | 4 | 11 | 22 | |
| 2415 | ADGRB3 levels | PROLV000040 | 2.25 | Protein levels | Stromal / connective | 34 | 5 | 8 | 25 | |
| 2416 | Histidine metabolites | METAB000008 | 2.25 | Metabolites | Granulosa cell | 3 | 0 | 3 | 9 | |
| 2417 | PPP1R12A/VEGFC ratio | PRORT001704 | 2.25 | Protein ratios | Lymphocyte | 3 | 4 | 15 | 46 | |
| 2418 | RNF149 levels | PROLV001745 | 2.25 | Protein levels | Myeloid | 4 | 2 | 6 | 10 | |
| 2419 | Multiple sclerosis | IMMUN000034 | 2.25 | Immunologic | Lymphocyte | 56 | 2 | 16 | 23 | |
| 2420 | PDLIM7/PLA2G4A ratio | PRORT001654 | 2.25 | Protein ratios | Platelet | 8 | 4 | 5 | 18 | |
| 2421 | PSME2/RBKS ratio | PRORT001713 | 2.25 | Protein ratios | Hepatocyte | 23 | 4 | 15 | 13 | |
| 2422 | SESTD1 levels | PROLV001838 | 2.25 | Protein levels | Muscle / cardiac | 12 | 4 | 8 | 23 | |
| 2423 | CNTN3/NCS1 ratio | PRORT000687 | 2.25 | Protein ratios | Hepatocyte | 45 | 1 | 8 | 16 | |
| 2424 | Brain functional activity | NIMAG000001 | 2.24 | Neuroimaging | Hepatocyte | 9 | 0 | 1 | 6 | |
| 2425 | Neoplasm, Skin | MALIG000034 | 2.24 | Malignancy | Myeloid | 88 | 4 | 12 | 22 | |
| 2426 | GFRA3/LAYN ratio | PRORT001211 | 2.24 | Protein ratios | Adipose | 4 | 3 | 4 | 12 | |
| 2427 | SRSF7 levels | PROLV001946 | 2.24 | Protein levels | Myeloid | 1 | 4 | 7 | 16 | |
| 2428 | SUSD1 levels | PROLV001978 | 2.23 | Protein levels | Vascular | 27 | 4 | 5 | 14 | |
| 2429 | RP2 levels | PROLV001752 | 2.23 | Protein levels | Vascular | 29 | 2 | 8 | 11 | |
| 2430 | DKK4 levels | PROLV000622 | 2.22 | Protein levels | Vascular | 53 | 2 | 10 | 18 | |
| 2431 | Corpus callosum volume | NIMAG000021 | 2.22 | Neuroimaging | Neural / glial | 35 | 1 | 3 | 10 | |
| 2432 | ANXA3 levels | PROLV000107 | 2.22 | Protein levels | Myeloid | 30 | 4 | 7 | 12 | |
| 2433 | NADK levels | PROLV001370 | 2.21 | Protein levels | Myeloid | 42 | 2 | 7 | 16 | |
| 2434 | APRT/PSME1 ratio | PRORT000137 | 2.20 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 33 | |
| 2435 | Corrective lens use | OPHTH000032 | 2.20 | Ophthalmic | Neural / glial | 66 | 8 | 14 | 25 | |
| 2436 | PAEP levels | PROLV001485 | 2.20 | Protein levels | Myeloid | 0 | 2 | 3 | 13 | |
| 2437 | Dietary preference | DTSUP000008 | 2.19 | Diet and Supplement | Neural / glial | 53 | 3 | 7 | 12 | |
| 2438 | SH2B3/SUGT1 ratio | PRORT001783 | 2.19 | Protein ratios | Muscle / cardiac | 24 | 3 | 9 | 23 | |
| 2439 | PLAUR/PRSS8 ratio | PRORT001679 | 2.19 | Protein ratios | Epithelial | 37 | 2 | 11 | 13 | |
| 2440 | GMFG levels | PROLV000901 | 2.18 | Protein levels | Myeloid | 17 | 4 | 9 | 23 | |
| 2441 | PLIN1 levels | PROLV001578 | 2.18 | Protein levels | Neural / glial | 0 | 2 | 3 | 12 | |
| 2442 | RABGAP1L levels | PROLV001702 | 2.18 | Protein levels | Muscle / cardiac | 7 | 3 | 10 | 23 | |
| 2443 | ITGAL levels | PROLV001108 | 2.18 | Protein levels | Lymphocyte | 15 | 2 | 17 | 37 | |
| 2444 | DECR1/MAP2K6 ratio | PRORT000882 | 2.17 | Protein ratios | Muscle / cardiac | 19 | 3 | 10 | 16 | |
| 2445 | PSRC1/SMAD1 ratio | PRORT001714 | 2.17 | Protein ratios | Muscle / cardiac | 1 | 3 | 13 | 28 | |
| 2446 | F2R levels | PROLV000745 | 2.17 | Protein levels | Lymphocyte | 23 | 2 | 5 | 21 | |
| 2447 | CCL19 levels | PROLV000285 | 2.17 | Protein levels | Lymphocyte | 61 | 1 | 10 | 16 | |
| 2448 | CDKN1A/TBL1X ratio | PRORT000573 | 2.17 | Protein ratios | Hepatocyte | 13 | 3 | 13 | 13 | |
| 2449 | F2R/GP6 ratio | PRORT001076 | 2.17 | Protein ratios | Myeloid | 5 | 2 | 6 | 19 | |
| 2450 | SLC39A14 levels | PROLV001880 | 2.16 | Protein levels | Hepatocyte | 97 | 1 | 6 | 9 | |
| 2451 | ANGPTL3/TFPI ratio | PRORT000099 | 2.16 | Protein ratios | Hepatocyte | 73 | 2 | 11 | 18 | |
| 2452 | C1QTNF1 levels | PROLV000224 | 2.16 | Protein levels | Neural / glial | 27 | 2 | 10 | 34 | |
| 2453 | FLRT2 levels | PROLV000814 | 2.16 | Protein levels | Hepatocyte | 50 | 1 | 6 | 14 | |
| 2454 | FKBP5/ZBTB16 ratio | PRORT001160 | 2.16 | Protein ratios | Muscle / cardiac | 21 | 1 | 4 | 12 | |
| 2455 | Lysine | METAB000026 | 2.15 | Metabolites | Hepatocyte | 1 | 2 | 7 | 16 | |
| 2456 | Bone mineral density | MSKEL000004 | 2.15 | Musculoskeletal | Stromal / connective | 350 | 3 | 8 | 10 | |
| 2457 | PPP1R2/TACC3 ratio | PRORT001705 | 2.15 | Protein ratios | Lymphocyte | 3 | 3 | 10 | 25 | |
| 2458 | DCXR/SCLY ratio | PRORT000878 | 2.14 | Protein ratios | Hepatocyte | 5 | 2 | 8 | 12 | |
| 2459 | MAVS/MZT1 ratio | PRORT001497 | 2.13 | Protein ratios | Muscle / cardiac | 0 | 4 | 13 | 23 | |
| 2460 | ZNF830 levels | PROLV002212 | 2.13 | Protein levels | B / plasma cell | 4 | 4 | 11 | 30 | |
| 2461 | Family history, asthma | IMMUN000047 | 2.13 | Immunologic | Lymphocyte | 5 | 3 | 17 | 26 | |
| 2462 | MSLN levels | PROLV001340 | 2.12 | Protein levels | Epithelial | 45 | 0 | 5 | 6 | |
| 2463 | Coffee preference | DTSUP000002 | 2.12 | Diet and Supplement | Neural / glial | 139 | 4 | 10 | 14 | |
| 2464 | C5 levels | PROLV000235 | 2.12 | Protein levels | Hepatocyte | 10 | 4 | 15 | 40 | |
| 2465 | Memory disorder | PSYCH000006 | 2.12 | Psychiatric | Neural / glial | 1 | 1 | 4 | 8 | |
| 2466 | ITGB1BP2/WASF1 ratio | PRORT001391 | 2.12 | Protein ratios | Myeloid | 0 | 3 | 9 | 24 | |
| 2467 | STK24 levels | PROLV001964 | 2.12 | Protein levels | Lymphocyte | 2 | 2 | 7 | 21 | |
| 2468 | NFATC1/SPRY2 ratio | PRORT001586 | 2.11 | Protein ratios | Hepatocyte | 0 | 3 | 10 | 32 | |
| 2469 | AXIN1/CALCOCO1 ratio | PRORT000165 | 2.11 | Protein ratios | Granulosa cell | 3 | 4 | 14 | 33 | |
| 2470 | LRP11/ROR1 ratio | PRORT001461 | 2.11 | Protein ratios | Vascular | 0 | 0 | 4 | 10 | |
| 2471 | Medication, bone metabolism | MSKEL000025 | 2.10 | Musculoskeletal | Lymphocyte | — | 2 | 10 | 27 | |
| 2472 | CIAPIN1/PLA2G4A ratio | PRORT000615 | 2.10 | Protein ratios | Myeloid | 0 | 2 | 6 | 14 | |
| 2473 | RNF41/WWP2 ratio | PRORT001743 | 2.10 | Protein ratios | Epithelial | 0 | 0 | 7 | 6 | |
| 2474 | GRAP2/PPP1R2 ratio | PRORT001243 | 2.10 | Protein ratios | Hepatocyte | 7 | 2 | 7 | 16 | |
| 2475 | EGLN1 levels | PROLV000688 | 2.10 | Protein levels | Lymphocyte | 10 | 5 | 9 | 39 | |
| 2476 | Neuropathic arthropathy | MSKEL000017 | 2.10 | Musculoskeletal | Myeloid | — | 1 | 7 | 11 | |
| 2477 | DKK1/PPCDC ratio | PRORT000899 | 2.09 | Protein ratios | Myeloid | 14 | 2 | 10 | 16 | |
| 2478 | SPOCK2 levels | PROLV001935 | 2.09 | Protein levels | Hepatocyte | 5 | 2 | 6 | 12 | |
| 2479 | CDH17/PTPRM ratio | PRORT000550 | 2.09 | Protein ratios | Lymphocyte | 10 | 1 | 14 | 25 | |
| 2480 | TNFRSF10A levels | PROLV002057 | 2.09 | Protein levels | Myeloid | 46 | 1 | 7 | 5 | |
| 2481 | PCDH17/ROBO1 ratio | PRORT001625 | 2.08 | Protein ratios | Granulosa cell | 9 | 2 | 4 | 8 | |
| 2482 | NID1/TIMP3 ratio | PRORT001590 | 2.08 | Protein ratios | Vascular | 24 | 1 | 7 | 11 | |
| 2483 | RGMB/THY1 ratio | PRORT001738 | 2.08 | Protein ratios | Hepatocyte | 1 | 2 | 6 | 12 | |
| 2484 | ALPI levels | PROLV000082 | 2.08 | Protein levels | Stromal / connective | 4 | 0 | 4 | 21 | |
| 2485 | Paradoxical eczema | IMMUN000036 | 2.08 | Immunologic | Myeloid | 0 | 1 | 6 | 16 | |
| 2486 | Bile acid metabolites | METAB000033 | 2.08 | Metabolites | Hepatocyte | 8 | 1 | 5 | 15 | |
| 2487 | Gastric ulcer | GASTR000048 | 2.07 | Gastrointestinal | Lymphocyte | 3 | 1 | 7 | 27 | |
| 2488 | GNLY/GZMA ratio | PRORT001221 | 2.06 | Protein ratios | Lymphocyte | 41 | 3 | 18 | 47 | |
| 2489 | Grey matter volume | NIMAG000023 | 2.06 | Neuroimaging | Stromal / connective | 53 | 0 | 0 | 0 | |
| 2490 | TNXB levels | PROLV002085 | 2.05 | Protein levels | Stromal / connective | 56 | 4 | 7 | 22 | |
| 2491 | PDCD6IP levels | PROLV001519 | 2.05 | Protein levels | Muscle / cardiac | 0 | 4 | 11 | 18 | |
| 2492 | CBLN4/RET ratio | PRORT000326 | 2.05 | Protein ratios | Vascular | 13 | 1 | 8 | 16 | |
| 2493 | Dizziness and giddiness | AUDIO000020 | 2.04 | Auditory | Neural / glial | 0 | 4 | 14 | 32 | |
| 2494 | Atherosclerosis | VASCU000006 | 2.04 | Vascular | Hepatocyte | 177 | 2 | 10 | 20 | |
| 2495 | HTRA2/TRIAP1 ratio | PRORT001313 | 2.04 | Protein ratios | Myeloid | 0 | 1 | 6 | 10 | |
| 2496 | CIAPIN1/VEGFC ratio | PRORT000619 | 2.04 | Protein ratios | Platelet | 3 | 2 | 9 | 30 | |
| 2497 | LYN levels | PROLV001251 | 2.04 | Protein levels | Myeloid | 41 | 2 | 7 | 13 | |
| 2498 | PDGFA/VEGFC ratio | PRORT001639 | 2.04 | Protein ratios | Hematopoietic progenitor | 8 | 4 | 13 | 22 | |
| 2499 | IL18RAP levels | PROLV001057 | 2.04 | Protein levels | B / plasma cell | 20 | 2 | 5 | 6 | |
| 2500 | Miscarriage | REPRO000038 | 2.04 | Reproductive | Lymphocyte | 0 | 2 | 15 | 31 | |
| 2501 | SYT1 levels | PROLV001985 | 2.04 | Protein levels | Granulosa cell | 25 | 1 | 6 | 12 | |
| 2502 | Nucleoside metabolites | METAB000061 | 2.03 | Metabolites | Vascular | 0 | 0 | 1 | 2 | |
| 2503 | PPP1R12A/SKAP2 ratio | PRORT001701 | 2.03 | Protein ratios | Hepatocyte | 9 | 2 | 7 | 13 | |
| 2504 | EBAG9/TBCB ratio | PRORT000961 | 2.03 | Protein ratios | Myeloid | 0 | 2 | 7 | 16 | |
| 2505 | FETUB levels | PROLV000790 | 2.03 | Protein levels | Hepatocyte | 44 | 1 | 7 | 7 | |
| 2506 | SCARA5/TGFBI ratio | PRORT001759 | 2.03 | Protein ratios | Hepatocyte | 10 | 3 | 6 | 12 | |
| 2507 | CD40/TIMP3 ratio | PRORT000446 | 2.03 | Protein ratios | Vascular | 9 | 1 | 4 | 7 | |
| 2508 | Risk-taking behaviour | BEHAV000013 | 2.02 | Behavioural | Neural / glial | 77 | 5 | 7 | 24 | |
| 2509 | EDAR/TREML2 ratio | PRORT000983 | 2.02 | Protein ratios | Platelet | 14 | 2 | 6 | 11 | |
| 2510 | MPHOSPH8/USP8 ratio | PRORT001555 | 2.02 | Protein ratios | Lymphocyte | 0 | 3 | 17 | 44 | |
| 2511 | DLK1/FAP ratio | PRORT000911 | 2.01 | Protein ratios | Adipose | 26 | 4 | 8 | 25 | |
| 2512 | INPP1/NT5C3A ratio | PRORT001359 | 2.01 | Protein ratios | Hepatocyte | 1 | 4 | 9 | 22 | |
| 2513 | AMBP/HAVCR1 ratio | PRORT000086 | 2.01 | Protein ratios | Hepatocyte | 10 | 1 | 8 | 9 | |
| 2514 | QPCT levels | PROLV001693 | 2.01 | Protein levels | Lymphocyte | 72 | 3 | 9 | 24 | |
| 2515 | LAIR1 levels | PROLV001176 | 2.01 | Protein levels | Myeloid | 23 | 4 | 9 | 17 | |
| 2516 | SCGB3A2 levels | PROLV001788 | 2.01 | Protein levels | Respiratory epithelium | 35 | 2 | 9 | 16 | |
| 2517 | BECN1 levels | PROLV000192 | 2.00 | Protein levels | Muscle / cardiac | 30 | 4 | 7 | 17 | |
| 2518 | INSR levels | PROLV001094 | 2.00 | Protein levels | Lymphocyte | 42 | 1 | 7 | 30 | |
| 2519 | Abnormal lung findings | RESPI000026 | 2.00 | Respiratory | Hepatocyte | 1 | 2 | 7 | 19 | |
| 2520 | OBP2B levels | PROLV001460 | 2.00 | Protein levels | Respiratory epithelium | 12 | 0 | 8 | 9 | |
| 2521 | CXCL12 levels | PROLV000578 | 2.00 | Protein levels | Lymphocyte | 15 | 2 | 7 | 18 | |
| 2522 | Heel quantitative ultrasound | MSKEL000005 | 2.00 | Musculoskeletal | Stromal / connective | 361 | 3 | 8 | 12 | |
| 2523 | CD244/EDAR ratio | PRORT000407 | 1.99 | Protein ratios | Hematopoietic progenitor | 8 | 4 | 5 | 12 | |
| 2524 | Metabolic disorder | METBL000014 | 1.99 | Metabolic | Hepatocyte | 114 | 1 | 7 | 15 | |
| 2525 | FCRL5/LY96 ratio | PRORT001134 | 1.99 | Protein ratios | B / plasma cell | 39 | 5 | 15 | 23 | |
| 2526 | MPIG6B levels | PROLV001335 | 1.98 | Protein levels | Myeloid | 38 | 2 | 5 | 13 | |
| 2527 | SCARF1/TNFRSF14 ratio | PRORT001762 | 1.98 | Protein ratios | Vascular | 11 | 1 | 2 | 9 | |
| 2528 | Glycan trait | METAB000054 | 1.98 | Metabolites | B / plasma cell | 70 | 2 | 6 | 26 | |
| 2529 | TRIM58 levels | PROLV002111 | 1.98 | Protein levels | Vascular | 3 | 2 | 7 | 10 | |
| 2530 | Metabolon metabolite | METAB000076 | 1.97 | Metabolites | Hepatocyte | 164 | 1 | 2 | 11 | |
| 2531 | ANXA4 levels | PROLV000108 | 1.97 | Protein levels | Myeloid | 31 | 2 | 6 | 17 | |
| 2532 | RTBDN levels | PROLV001760 | 1.97 | Protein levels | B / plasma cell | 12 | 1 | 6 | 12 | |
| 2533 | ITPA levels | PROLV001121 | 1.97 | Protein levels | Muscle / cardiac | 0 | 3 | 7 | 21 | |
| 2534 | Pregnancy complication, oedema | REPRO000032 | 1.97 | Reproductive | B / plasma cell | 3 | 0 | 3 | 2 | |
| 2535 | Diabetes, type 2 | METBL000034 | 1.96 | Metabolic | Hepatocyte | 723 | 0 | 3 | 5 | |
| 2536 | CHRDL1/SMOC2 ratio | PRORT000614 | 1.96 | Protein ratios | Adipose | 3 | 3 | 7 | 14 | |
| 2537 | SEMA3G levels | PROLV001808 | 1.96 | Protein levels | Hepatocyte | 80 | 1 | 6 | 8 | |
| 2538 | CLEC11A levels | PROLV000445 | 1.96 | Protein levels | Hematopoietic progenitor | 65 | 3 | 5 | 10 | |
| 2539 | SNAP23 levels | PROLV001905 | 1.95 | Protein levels | Platelet | 23 | 2 | 5 | 16 | |
| 2540 | CDSN/KLK8 ratio | PRORT000582 | 1.95 | Protein ratios | Gastrointestinal epithelium | 22 | 1 | 12 | 19 | |
| 2541 | OSMR levels | PROLV001476 | 1.95 | Protein levels | Lymphocyte | 78 | 3 | 14 | 34 | |
| 2542 | MAP2 levels | PROLV001265 | 1.95 | Protein levels | Muscle / cardiac | 9 | 2 | 5 | 9 | |
| 2543 | Labour complication | REPRO000037 | 1.95 | Reproductive | Stromal / connective | 0 | 1 | 4 | 7 | |
| 2544 | CD69/EDAR ratio | PRORT000491 | 1.95 | Protein ratios | Myeloid | 21 | 4 | 11 | 22 | |
| 2545 | BAP18 levels | PROLV000179 | 1.94 | Protein levels | Vascular | 44 | 4 | 13 | 39 | |
| 2546 | FKBP5 levels | PROLV000810 | 1.93 | Protein levels | Muscle / cardiac | 14 | 2 | 5 | 18 | |
| 2547 | MMP1/MMP3 ratio | PRORT001541 | 1.93 | Protein ratios | Hematopoietic progenitor | 1 | 2 | 8 | 9 | |
| 2548 | PRG3 levels | PROLV001629 | 1.93 | Protein levels | Lymphocyte | 126 | 2 | 8 | 27 | |
| 2549 | Macular degeneration | OPHTH000036 | 1.93 | Ophthalmic | Hepatocyte | 106 | 2 | 7 | 15 | |
| 2550 | ACADSB levels | PROLV000009 | 1.93 | Protein levels | Neural / glial | 22 | 4 | 10 | 20 | |
| 2551 | LTBP3 levels | PROLV001243 | 1.92 | Protein levels | Hepatocyte | 52 | 1 | 8 | 19 | |
| 2552 | Valine | METAB000032 | 1.92 | Metabolites | Hepatocyte | 209 | 2 | 6 | 18 | |
| 2553 | ITGB1/NCAM1 ratio | PRORT001378 | 1.92 | Protein ratios | Hepatocyte | 41 | 4 | 10 | 22 | |
| 2554 | Smoking effects on COPD | RESPI000012 | 1.92 | Respiratory | Hepatocyte | 20 | 1 | 4 | 13 | |
| 2555 | RHOC levels | PROLV001732 | 1.92 | Protein levels | Myeloid | 31 | 2 | 6 | 15 | |
| 2556 | POF1B levels | PROLV001597 | 1.92 | Protein levels | Myeloid | 7 | 3 | 17 | 20 | |
| 2557 | HLA-DQA2 levels | PROLV000974 | 1.92 | Protein levels | Neural / glial | 5 | 4 | 7 | 9 | |
| 2558 | CD69/CDKN2D ratio | PRORT000487 | 1.92 | Protein ratios | Vascular | 6 | 3 | 8 | 16 | |
| 2559 | PNLIPRP2 levels | PROLV001593 | 1.91 | Protein levels | Granulosa cell | 13 | 1 | 5 | 13 | |
| 2560 | CXCL11/VTA1 ratio | PRORT000820 | 1.91 | Protein ratios | Hepatocyte | 5 | 3 | 12 | 26 | |
| 2561 | SLITRK1 levels | PROLV001888 | 1.91 | Protein levels | Myeloid | 39 | 1 | 8 | 10 | |
| 2562 | WASL levels | PROLV002187 | 1.91 | Protein levels | B / plasma cell | 54 | 2 | 8 | 16 | |
| 2563 | HLA-A levels | PROLV000972 | 1.91 | Protein levels | Myeloid | 143 | 3 | 11 | 29 | |
| 2564 | TNFRSF4/TNFRSF8 ratio | PRORT001853 | 1.91 | Protein ratios | Vascular | 2 | 2 | 6 | 10 | |
| 2565 | GP1BA/HBEGF ratio | PRORT001225 | 1.90 | Protein ratios | Myeloid | 30 | 2 | 11 | 18 | |
| 2566 | CLEC1B/HEXIM1 ratio | PRORT000639 | 1.90 | Protein ratios | Myeloid | 7 | 1 | 6 | 15 | |
| 2567 | Flavour preference | DTSUP000022 | 1.90 | Diet and Supplement | Neural / glial | 94 | 3 | 8 | 18 | |
| 2568 | Gut microbial abundance, CAG-273 | GASTR000022 | 1.90 | Gastrointestinal | Lymphocyte | 0 | 1 | 5 | 15 | |
| 2569 | DCTN1 levels | PROLV000603 | 1.89 | Protein levels | Myeloid | 33 | 1 | 3 | 10 | |
| 2570 | DAG1/F2R ratio | PRORT000846 | 1.89 | Protein ratios | Myeloid | 18 | 3 | 8 | 18 | |
| 2571 | Cancer, Skin | MALIG000028 | 1.89 | Malignancy | Lymphocyte | 302 | 3 | 14 | 19 | |
| 2572 | GP6/TMSB10 ratio | PRORT001237 | 1.89 | Protein ratios | Myeloid | 4 | 2 | 6 | 17 | |
| 2573 | TIA1/USP8 ratio | PRORT001837 | 1.89 | Protein ratios | Hepatocyte | 12 | 3 | 11 | 37 | |
| 2574 | Leukoencephalopathy | NEURO000004 | 1.89 | Neurologic | Stromal / connective | 2 | 2 | 10 | 7 | |
| 2575 | Precerebral arterial stenosis and occlusion | VASCU000016 | 1.88 | Vascular | Stromal / connective | 91 | 2 | 11 | 22 | |
| 2576 | ESAM/VSIR ratio | PRORT001070 | 1.88 | Protein ratios | Vascular | 7 | 2 | 10 | 16 | |
| 2577 | TNFAIP2 levels | PROLV002054 | 1.88 | Protein levels | Myeloid | 10 | 2 | 4 | 10 | |
| 2578 | NECTIN2/VSIR ratio | PRORT001582 | 1.88 | Protein ratios | Hepatocyte | 42 | 2 | 8 | 15 | |
| 2579 | CD209/GP2 ratio | PRORT000397 | 1.88 | Protein ratios | Epithelial | 36 | 0 | 3 | 6 | |
| 2580 | FYN levels | PROLV000843 | 1.87 | Protein levels | Muscle / cardiac | 0 | 3 | 12 | 32 | |
| 2581 | EDAR/TXNDC5 ratio | PRORT000984 | 1.87 | Protein ratios | Myeloid | 50 | 2 | 7 | 16 | |
| 2582 | ANXA10 levels | PROLV000105 | 1.87 | Protein levels | Myeloid | 9 | 0 | 4 | 4 | |
| 2583 | CCN3/PGF ratio | PRORT000374 | 1.86 | Protein ratios | Vascular | 2 | 4 | 6 | 28 | |
| 2584 | SMOC1 levels | PROLV001899 | 1.86 | Protein levels | Hepatocyte | 129 | 1 | 6 | 15 | |
| 2585 | Stevens-Johnson syndrome, SJS | IMMUN000001 | 1.86 | Immunologic | Lymphocyte | 3 | 2 | 10 | 28 | |
| 2586 | ITGB1BP2/MED18 ratio | PRORT001384 | 1.85 | Protein ratios | Muscle / cardiac | 0 | 4 | 7 | 17 | |
| 2587 | DCXR levels | PROLV000606 | 1.85 | Protein levels | Hepatocyte | 72 | 2 | 8 | 14 | |
| 2588 | CLEC1B/TXNDC5 ratio | PRORT000651 | 1.84 | Protein ratios | Hepatocyte | 7 | 1 | 7 | 21 | |
| 2589 | DXO levels | PROLV000665 | 1.84 | Protein levels | Lymphocyte | 32 | 5 | 11 | 35 | |
| 2590 | Heart failure | CARDI000007 | 1.84 | Cardiac | Muscle / cardiac | 37 | 2 | 3 | 10 | |
| 2591 | LAMP2 levels | PROLV001181 | 1.84 | Protein levels | Myeloid | 51 | 1 | 8 | 7 | |
| 2592 | TRIAP1 levels | PROLV002105 | 1.84 | Protein levels | Myeloid | 13 | 4 | 9 | 19 | |
| 2593 | Medication, lipid-lowering | METBL000028 | 1.84 | Metabolic | Hepatocyte | 589 | 1 | 7 | 4 | |
| 2594 | HIP1R levels | PROLV000970 | 1.84 | Protein levels | Myeloid | 1 | 2 | 12 | 23 | |
| 2595 | SELP/VSIR ratio | PRORT001770 | 1.84 | Protein ratios | Myeloid | 2 | 2 | 7 | 10 | |
| 2596 | MSRA levels | PROLV001343 | 1.83 | Protein levels | Myeloid | 18 | 2 | 4 | 15 | |
| 2597 | CGA levels | PROLV000420 | 1.83 | Protein levels | Lymphocyte | 0 | 0 | 4 | 10 | |
| 2598 | White matter microstructure | NIMAG000013 | 1.83 | Neuroimaging | Neural / glial | 96 | 0 | 0 | 3 | |
| 2599 | C4 levels | PROLV000233 | 1.83 | Protein levels | Vascular | 4 | 0 | 3 | 8 | |
| 2600 | METAP1D/VASH1 ratio | PRORT001522 | 1.83 | Protein ratios | Hematopoietic progenitor | 4 | 2 | 5 | 11 | |
| 2601 | CD244/CRTAM ratio | PRORT000406 | 1.82 | Protein ratios | Lymphocyte | 30 | 2 | 14 | 25 | |
| 2602 | BLVRB/HMBS ratio | PRORT000243 | 1.82 | Protein ratios | Neural / glial | 14 | 5 | 14 | 29 | |
| 2603 | Hashimoto thyroiditis | IMMUN000028 | 1.82 | Immunologic | Neural / glial | — | 2 | 4 | 8 | |
| 2604 | ICAM2/SELE ratio | PRORT001325 | 1.82 | Protein ratios | Granulosa cell | 0 | 2 | 5 | 17 | |
| 2605 | Movement disorder | NEURO000015 | 1.82 | Neurologic | Neural / glial | 43 | 2 | 7 | 11 | |
| 2606 | CPXM1/MDK ratio | PRORT000735 | 1.82 | Protein ratios | Hematopoietic progenitor | 20 | 3 | 6 | 22 | |
| 2607 | DKK4/REG1A ratio | PRORT000909 | 1.82 | Protein ratios | Hepatocyte | 32 | 2 | 8 | 16 | |
| 2608 | EFCAB14 levels | PROLV000678 | 1.82 | Protein levels | Muscle / cardiac | 16 | 1 | 4 | 18 | |
| 2609 | BSG/LY9 ratio | PRORT000249 | 1.81 | Protein ratios | B / plasma cell | 12 | 1 | 6 | 19 | |
| 2610 | PILRA levels | PROLV001560 | 1.81 | Protein levels | Myeloid | 54 | 1 | 9 | 10 | |
| 2611 | TYMP levels | PROLV002128 | 1.81 | Protein levels | Vascular | 4 | 2 | 8 | 24 | |
| 2612 | BOLA2 or BOLA2B levels | PROLV000208 | 1.81 | Protein levels | Lymphocyte | 3 | 2 | 7 | 24 | |
| 2613 | ITIH4 levels | PROLV001119 | 1.80 | Protein levels | Hepatocyte | 94 | 2 | 8 | 17 | |
| 2614 | Herpes zoster | IMMUN000064 | 1.80 | Immunologic | Lymphocyte | 0 | 1 | 3 | 11 | |
| 2615 | DCTN1/SCAMP3 ratio | PRORT000873 | 1.80 | Protein ratios | Neural / glial | 15 | 4 | 12 | 24 | |
| 2616 | Phosphate | METAB000048 | 1.80 | Metabolites | Hepatocyte | 604 | 1 | 7 | 10 | |
| 2617 | BIRC2/CD40LG ratio | PRORT000235 | 1.80 | Protein ratios | Hepatocyte | 0 | 3 | 10 | 29 | |
| 2618 | IRAK1/NFATC1 ratio | PRORT001368 | 1.80 | Protein ratios | Hepatocyte | 1 | 3 | 8 | 22 | |
| 2619 | GHRL levels | PROLV000886 | 1.80 | Protein levels | Hepatocyte | 39 | 2 | 6 | 15 | |
| 2620 | PGR levels | PROLV001548 | 1.79 | Protein levels | B / plasma cell | 21 | 3 | 12 | 30 | |
| 2621 | CC2D1A/STAMBP ratio | PRORT000328 | 1.79 | Protein ratios | Lymphocyte | 1 | 1 | 15 | 21 | |
| 2622 | SERPINB1 levels | PROLV001823 | 1.79 | Protein levels | Myeloid | 23 | 5 | 6 | 19 | |
| 2623 | CA2/CA3 ratio | PRORT000274 | 1.79 | Protein ratios | Muscle / cardiac | 0 | 3 | 11 | 23 | |
| 2624 | SMPDL3A levels | PROLV001903 | 1.78 | Protein levels | Hepatocyte | 198 | 1 | 5 | 8 | |
| 2625 | STX4 levels | PROLV001968 | 1.78 | Protein levels | Vascular | 9 | 3 | 8 | 15 | |
| 2626 | CD55/PTGDS ratio | PRORT000471 | 1.78 | Protein ratios | Vascular | 1 | 3 | 8 | 21 | |
| 2627 | HSPA1A levels | PROLV000996 | 1.78 | Protein levels | Lymphocyte | 33 | 3 | 14 | 40 | |
| 2628 | B4GALT1 levels | PROLV000171 | 1.78 | Protein levels | Renal epithelium | 30 | 0 | 6 | 1 | |
| 2629 | CST3/TFF3 ratio | PRORT000788 | 1.78 | Protein ratios | Adipose | 7 | 1 | 9 | 12 | |
| 2630 | Gynaecomastia | BREAS000003 | 1.78 | Breast | Granulosa cell | 0 | 1 | 4 | 11 | |
| 2631 | CST6/FABP9 ratio | PRORT000790 | 1.77 | Protein ratios | Cutaneous epithelium | 12 | 0 | 6 | 10 | |
| 2632 | COX5B levels | PROLV000500 | 1.77 | Protein levels | Myeloid | 2 | 2 | 7 | 10 | |
| 2633 | Varicose veins, VV | VASCU000061 | 1.76 | Vascular | Vascular | 132 | 1 | 4 | 11 | |
| 2634 | CLEC14A/EPHB4 ratio | PRORT000626 | 1.76 | Protein ratios | Vascular | 10 | 3 | 7 | 17 | |
| 2635 | ACOT13 levels | PROLV000013 | 1.76 | Protein levels | Stromal / connective | 16 | 3 | 5 | 13 | |
| 2636 | PLXNB2/SEMA7A ratio | PRORT001690 | 1.76 | Protein ratios | B / plasma cell | 8 | 2 | 8 | 21 | |
| 2637 | CD40 levels | PROLV000340 | 1.76 | Protein levels | Platelet | 9 | 1 | 2 | 4 | |
| 2638 | Medical conditions, allergy etc, none | MISCL000026 | 1.76 | Miscellaneous | Lymphocyte | 251 | 2 | 12 | 15 | |
| 2639 | IRAK1 levels | PROLV001097 | 1.76 | Protein levels | Vascular | 10 | 3 | 10 | 15 | |
| 2640 | CALB2 levels | PROLV000254 | 1.76 | Protein levels | Pancreatic epithelium | 0 | 1 | 6 | 12 | |
| 2641 | CCN5 levels | PROLV000305 | 1.76 | Protein levels | Vascular | 15 | 0 | 5 | 12 | |
| 2642 | ADAMTS8 levels | PROLV000035 | 1.76 | Protein levels | Muscle / cardiac | 48 | 3 | 5 | 11 | |
| 2643 | Diffuse idiopathic skeletal hyperostosis | MSKEL000074 | 1.75 | Musculoskeletal | Hematopoietic progenitor | 1 | 2 | 6 | 16 | |
| 2644 | HS6ST2 levels | PROLV000991 | 1.75 | Protein levels | Muscle / cardiac | 28 | 3 | 7 | 15 | |
| 2645 | GOPC levels | PROLV000910 | 1.75 | Protein levels | Myeloid | 27 | 1 | 7 | 15 | |
| 2646 | DKK1/VEGFC ratio | PRORT000905 | 1.75 | Protein ratios | Muscle / cardiac | 10 | 1 | 7 | 12 | |
| 2647 | Cancer, Thyroid | MALIG000032 | 1.75 | Malignancy | Lymphocyte | 2 | 1 | 9 | 30 | |
| 2648 | DLK1/RGMB ratio | PRORT000913 | 1.75 | Protein ratios | Hepatocyte | 11 | 4 | 9 | 23 | |
| 2649 | IL1R2/MEGF9 ratio | PRORT001349 | 1.75 | Protein ratios | Hepatocyte | 31 | 2 | 9 | 13 | |
| 2650 | BLNK levels | PROLV000200 | 1.75 | Protein levels | B / plasma cell | 0 | 3 | 15 | 27 | |
| 2651 | Influenza | IMMUN000065 | 1.74 | Immunologic | B / plasma cell | 21 | 3 | 6 | 11 | |
| 2652 | PPP3R1 levels | PROLV001620 | 1.74 | Protein levels | Myeloid | 20 | 2 | 10 | 18 | |
| 2653 | Heart failure, congestive | CARDI000004 | 1.74 | Cardiac | Muscle / cardiac | 6 | 2 | 5 | 14 | |
| 2654 | B4GALT1/B4GAT1 ratio | PRORT000187 | 1.74 | Protein ratios | Hepatocyte | 18 | 1 | 10 | 13 | |
| 2655 | Upper gastrointestinal disorder | GASTR000054 | 1.74 | Gastrointestinal | Myeloid | 0 | 1 | 7 | 13 | |
| 2656 | STK4 levels | PROLV001965 | 1.74 | Protein levels | Myeloid | 9 | 3 | 10 | 17 | |
| 2657 | CX3CL1/RGMB ratio | PRORT000811 | 1.73 | Protein ratios | Vascular | 14 | 1 | 7 | 18 | |
| 2658 | HEXIM1/IKBKG ratio | PRORT001276 | 1.73 | Protein ratios | Vascular | 0 | 0 | 8 | 20 | |
| 2659 | ABHD14B/APRT ratio | PRORT000003 | 1.73 | Protein ratios | Myeloid | 8 | 4 | 11 | 18 | |
| 2660 | CRTAM/LY9 ratio | PRORT000772 | 1.73 | Protein ratios | Lymphocyte | 31 | 3 | 16 | 28 | |
| 2661 | APP/VEGFC ratio | PRORT000132 | 1.73 | Protein ratios | Platelet | 0 | 4 | 8 | 14 | |
| 2662 | HMBS/PSMG3 ratio | PRORT001289 | 1.73 | Protein ratios | Hepatocyte | 15 | 4 | 10 | 29 | |
| 2663 | ENO2/MGLL ratio | PRORT001026 | 1.72 | Protein ratios | Muscle / cardiac | 7 | 5 | 9 | 30 | |
| 2664 | MAVS/RNF41 ratio | PRORT001499 | 1.72 | Protein ratios | Muscle / cardiac | 19 | 5 | 9 | 16 | |
| 2665 | CHMP1A levels | PROLV000431 | 1.72 | Protein levels | Myeloid | 11 | 4 | 7 | 15 | |
| 2666 | Diabetes, type 2, autoimmune subtype | IMMUN000013 | 1.72 | Immunologic | Myeloid | — | 1 | 7 | 29 | |
| 2667 | EIF4B levels | PROLV000695 | 1.72 | Protein levels | Stromal / connective | 2 | 3 | 6 | 31 | |
| 2668 | Epigenetic age acceleration | AGING000002 | 1.71 | Aging | Hematopoietic progenitor | 25 | 1 | 3 | 22 | |
| 2669 | USO1 levels | PROLV002144 | 1.71 | Protein levels | Platelet | 10 | 4 | 7 | 19 | |
| 2670 | BACH1/PDLIM7 ratio | PRORT000197 | 1.71 | Protein ratios | Platelet | 0 | 5 | 9 | 20 | |
| 2671 | Eye disorder | OPHTH000008 | 1.71 | Ophthalmic | Neural / glial | 4 | 1 | 1 | 7 | |
| 2672 | FHIT/PRTFDC1 ratio | PRORT001148 | 1.71 | Protein ratios | Hepatocyte | 0 | 2 | 5 | 12 | |
| 2673 | FURIN/PLA2G15 ratio | PRORT001185 | 1.70 | Protein ratios | Adipose | 9 | 2 | 8 | 18 | |
| 2674 | CSRP3 levels | PROLV000547 | 1.70 | Protein levels | Muscle / cardiac | 0 | 3 | 9 | 22 | |
| 2675 | PPBP levels | PROLV001604 | 1.70 | Protein levels | Neural / glial | 68 | 3 | 9 | 15 | |
| 2676 | PDCD1/TNFRSF8 ratio | PRORT001630 | 1.70 | Protein ratios | B / plasma cell | 33 | 3 | 17 | 35 | |
| 2677 | DPP6/NRCAM ratio | PRORT000946 | 1.70 | Protein ratios | Epithelial | 13 | 0 | 5 | 7 | |
| 2678 | TNFRSF10C levels | PROLV002059 | 1.69 | Protein levels | Myeloid | 116 | 1 | 5 | 7 | |
| 2679 | KLRB1 levels | PROLV001161 | 1.69 | Protein levels | Lymphocyte | 88 | 2 | 17 | 26 | |
| 2680 | BACH1/SNAP23 ratio | PRORT000198 | 1.69 | Protein ratios | Myeloid | 0 | 3 | 15 | 19 | |
| 2681 | Urinary metabolite ratio | METAB000057 | 1.68 | Metabolites | Hepatocyte | 1 | 1 | 4 | 17 | |
| 2682 | DAG1 levels | PROLV000592 | 1.68 | Protein levels | Lymphocyte | 4 | 4 | 10 | 23 | |
| 2683 | BACH1/EIF4G1 ratio | PRORT000194 | 1.68 | Protein ratios | Muscle / cardiac | 0 | 1 | 6 | 20 | |
| 2684 | AP3B1 levels | PROLV000111 | 1.68 | Protein levels | Stromal / connective | 3 | 2 | 6 | 12 | |
| 2685 | Biliverdin | HPBIL000018 | 1.68 | Hepatopancreatobiliary | Lymphocyte | 0 | 0 | 10 | 17 | |
| 2686 | YTHDF3 levels | PROLV002207 | 1.68 | Protein levels | Myeloid | 27 | 1 | 6 | 6 | |
| 2687 | Trauma exposure | PSYCH000054 | 1.68 | Psychiatric | Neural / glial | 32 | 2 | 6 | 14 | |
| 2688 | CD300LG/DSG2 ratio | PRORT000435 | 1.67 | Protein ratios | Vascular | 16 | 1 | 5 | 9 | |
| 2689 | SSC4D levels | PROLV001947 | 1.67 | Protein levels | Hepatocyte | 51 | 3 | 8 | 15 | |
| 2690 | SERPINF2 levels | PROLV001833 | 1.67 | Protein levels | Hepatocyte | 42 | 2 | 9 | 10 | |
| 2691 | FXN/TRIAP1 ratio | PRORT001195 | 1.67 | Protein ratios | Myeloid | 1 | 2 | 6 | 11 | |
| 2692 | SUSD2 levels | PROLV001979 | 1.67 | Protein levels | B / plasma cell | 15 | 3 | 8 | 14 | |
| 2693 | APOL1 levels | PROLV000127 | 1.67 | Protein levels | Hepatocyte | 130 | 1 | 7 | 6 | |
| 2694 | SLAMF7 levels | PROLV001876 | 1.67 | Protein levels | Myeloid | 126 | 3 | 7 | 14 | |
| 2695 | CD164/PARK7 ratio | PRORT000389 | 1.66 | Protein ratios | Neural / glial | 0 | 6 | 10 | 25 | |
| 2696 | IPCEF1/TBCC ratio | PRORT001365 | 1.66 | Protein ratios | B / plasma cell | 1 | 1 | 11 | 17 | |
| 2697 | FCRL6/KLRD1 ratio | PRORT001138 | 1.66 | Protein ratios | Lymphocyte | 19 | 5 | 13 | 39 | |
| 2698 | DNAJA2 levels | PROLV000629 | 1.66 | Protein levels | Vascular | 25 | 3 | 5 | 16 | |
| 2699 | IGFBP6/SMOC2 ratio | PRORT001338 | 1.66 | Protein ratios | Adipose | 2 | 3 | 8 | 13 | |
| 2700 | Cystatin C | NEPHR000019 | 1.66 | Nephrourologic | Myeloid | 898 | 1 | 7 | 9 | |
| 2701 | FADD/PLIN3 ratio | PRORT001108 | 1.66 | Protein ratios | Hepatocyte | 8 | 2 | 7 | 16 | |
| 2702 | Respiratory insufficiency | RESPI000031 | 1.65 | Respiratory | Hepatocyte | 0 | 4 | 10 | 29 | |
| 2703 | DAG1/PDGFB ratio | PRORT000851 | 1.65 | Protein ratios | Myeloid | 16 | 2 | 8 | 10 | |
| 2704 | CXCL5 levels | PROLV000584 | 1.65 | Protein levels | Platelet | 0 | 1 | 4 | 10 | |
| 2705 | CLEC1A/GPR37 ratio | PRORT000631 | 1.65 | Protein ratios | Muscle / cardiac | 25 | 3 | 8 | 20 | |
| 2706 | ITGB1BP2/LAT2 ratio | PRORT001383 | 1.65 | Protein ratios | Platelet | 15 | 1 | 6 | 15 | |
| 2707 | ICAM5 levels | PROLV001008 | 1.64 | Protein levels | Myeloid | 6 | 0 | 3 | 9 | |
| 2708 | DKK1/IPCEF1 ratio | PRORT000895 | 1.64 | Protein ratios | Lymphocyte | 2 | 3 | 14 | 36 | |
| 2709 | GPI levels | PROLV000923 | 1.64 | Protein levels | Myeloid | 8 | 1 | 1 | 8 | |
| 2710 | ZNRD2 levels | PROLV002213 | 1.64 | Protein levels | B / plasma cell | 62 | 2 | 14 | 25 | |
| 2711 | Pneumonia | IMMUN000069 | 1.64 | Immunologic | Hepatocyte | 27 | 1 | 4 | 13 | |
| 2712 | HEXIM1/TRIAP1 ratio | PRORT001281 | 1.64 | Protein ratios | Myeloid | 2 | 3 | 17 | 30 | |
| 2713 | CCL5/RARRES2 ratio | PRORT000357 | 1.64 | Protein ratios | Myeloid | 12 | 1 | 3 | 15 | |
| 2714 | TARBP2/TDRKH ratio | PRORT001826 | 1.64 | Protein ratios | Granulosa cell | 0 | 3 | 8 | 16 | |
| 2715 | MTDH levels | PROLV001346 | 1.63 | Protein levels | Myeloid | 3 | 2 | 10 | 18 | |
| 2716 | CD46/NID1 ratio | PRORT000457 | 1.63 | Protein ratios | Myeloid | 5 | 2 | 8 | 17 | |
| 2717 | FST levels | PROLV000829 | 1.63 | Protein levels | Granulosa cell | 34 | 2 | 6 | 15 | |
| 2718 | CD34 levels | PROLV000336 | 1.63 | Protein levels | Stromal / connective | 67 | 3 | 10 | 21 | |
| 2719 | BCAM/SEMA7A ratio | PRORT000213 | 1.63 | Protein ratios | Myeloid | 5 | 1 | 8 | 11 | |
| 2720 | NECTIN2/TNFRSF14 ratio | PRORT001580 | 1.63 | Protein ratios | Vascular | 3 | 0 | 7 | 17 | |
| 2721 | Skin sebum | DERMA000036 | 1.63 | Dermatologic | Stromal / connective | 0 | 2 | 6 | 12 | |
| 2722 | Betaine | METAB000041 | 1.63 | Metabolites | Hepatocyte | 7 | 0 | 2 | 7 | |
| 2723 | Lysophosphatidylcholines | LIPID000054 | 1.63 | Lipids | Neural / glial | 26 | 2 | 4 | 15 | |
| 2724 | L3HYPDH levels | PROLV001172 | 1.62 | Protein levels | Myeloid | 37 | 4 | 8 | 12 | |
| 2725 | TIMP3/ZBTB16 ratio | PRORT001838 | 1.62 | Protein ratios | Vascular | 1 | 2 | 7 | 20 | |
| 2726 | VNN1 levels | PROLV002164 | 1.62 | Protein levels | Hepatocyte | 55 | 3 | 12 | 25 | |
| 2727 | CXCL3/CXCL5 ratio | PRORT000825 | 1.62 | Protein ratios | Myeloid | 8 | 3 | 14 | 24 | |
| 2728 | CDKN1A/NCK2 ratio | PRORT000570 | 1.62 | Protein ratios | Vascular | 14 | 2 | 9 | 17 | |
| 2729 | NFATC1/TJAP1 ratio | PRORT001587 | 1.62 | Protein ratios | Muscle / cardiac | 0 | 1 | 6 | 8 | |
| 2730 | NPC2 levels | PROLV001419 | 1.62 | Protein levels | Myeloid | 24 | 1 | 5 | 9 | |
| 2731 | CD74/NPDC1 ratio | PRORT000506 | 1.62 | Protein ratios | Lymphocyte | 43 | 3 | 22 | 25 | |
| 2732 | CLC levels | PROLV000443 | 1.62 | Protein levels | Lymphocyte | 65 | 3 | 19 | 17 | |
| 2733 | CHAC2 levels | PROLV000422 | 1.62 | Protein levels | Vascular | 4 | 3 | 10 | 21 | |
| 2734 | DAG1/SCARF1 ratio | PRORT000853 | 1.61 | Protein ratios | Myeloid | 7 | 3 | 5 | 11 | |
| 2735 | Liver function | HPBIL000021 | 1.61 | Hepatopancreatobiliary | Hepatocyte | 106 | 1 | 7 | 8 | |
| 2736 | JAM2/THBD ratio | PRORT001398 | 1.61 | Protein ratios | Vascular | 26 | 1 | 5 | 14 | |
| 2737 | CSF unidentified metabolite | METAB000075 | 1.61 | Metabolites | Muscle / cardiac | 1 | 0 | 2 | 3 | |
| 2738 | DNAJB14 levels | PROLV000631 | 1.61 | Protein levels | Muscle / cardiac | 12 | 2 | 3 | 16 | |
| 2739 | Bilirubin metabolism disorder | HPBIL000003 | 1.61 | Hepatopancreatobiliary | Hepatocyte | 20 | 2 | 9 | 16 | |
| 2740 | GGCT levels | PROLV000881 | 1.60 | Protein levels | Lymphocyte | 3 | 4 | 9 | 32 | |
| 2741 | PVR levels | PROLV001687 | 1.60 | Protein levels | Hepatocyte | 54 | 1 | 9 | 10 | |
| 2742 | LGALS1 levels | PROLV001201 | 1.60 | Protein levels | Vascular | 9 | 2 | 4 | 16 | |
| 2743 | Operation, gastrointestinal | GASTR000039 | 1.60 | Gastrointestinal | Hepatocyte | 208 | 1 | 2 | 11 | |
| 2744 | Ceramides | LIPID000065 | 1.60 | Lipids | Hepatocyte | 6 | 1 | 3 | 15 | |
| 2745 | ADGRG2/SDC1 ratio | PRORT000037 | 1.60 | Protein ratios | Melanocyte | 30 | 1 | 8 | 8 | |
| 2746 | CHI3L1 levels | PROLV000428 | 1.60 | Protein levels | Hepatocyte | 54 | 1 | 7 | 13 | |
| 2747 | PLAT levels | PROLV001571 | 1.59 | Protein levels | Hepatocyte | 64 | 2 | 8 | 18 | |
| 2748 | PDGFA/SERPINE1 ratio | PRORT001635 | 1.59 | Protein ratios | Hematopoietic progenitor | 33 | 5 | 9 | 12 | |
| 2749 | MGLL/PLA2G4A ratio | PRORT001529 | 1.58 | Protein ratios | Hepatocyte | 33 | 1 | 8 | 7 | |
| 2750 | CRTAM/PDCD1 ratio | PRORT000773 | 1.58 | Protein ratios | Lymphocyte | 7 | 2 | 19 | 43 | |
| 2751 | CDKN1A/YES1 ratio | PRORT000576 | 1.58 | Protein ratios | Muscle / cardiac | 8 | 4 | 11 | 28 | |
| 2752 | DSG3/FABP9 ratio | PRORT000953 | 1.58 | Protein ratios | Cutaneous epithelium | 2 | 0 | 4 | 6 | |
| 2753 | CD22/CD79B ratio | PRORT000399 | 1.58 | Protein ratios | B / plasma cell | 16 | 1 | 7 | 10 | |
| 2754 | ANGPT1/CCN2 ratio | PRORT000092 | 1.57 | Protein ratios | Myeloid | 5 | 3 | 12 | 14 | |
| 2755 | GSTT2 levels | PROLV000942 | 1.57 | Protein levels | Gastrointestinal epithelium | 0 | 0 | 7 | 8 | |
| 2756 | C2/SSC5D ratio | PRORT000265 | 1.57 | Protein ratios | Vascular | 15 | 1 | 6 | 10 | |
| 2757 | Fatty liver disease, nonalcoholic | HPBIL000031 | 1.56 | Hepatopancreatobiliary | Vascular | 19 | 1 | 7 | 16 | |
| 2758 | Eyelid disorder | OPHTH000019 | 1.56 | Ophthalmic | Adipose | 14 | 1 | 1 | 3 | |
| 2759 | BAMBI levels | PROLV000177 | 1.56 | Protein levels | Stromal / connective | 10 | 0 | 1 | 10 | |
| 2760 | INHBB levels | PROLV001087 | 1.56 | Protein levels | Hepatocyte | 38 | 6 | 10 | 14 | |
| 2761 | PPP1R12A/TXNDC5 ratio | PRORT001703 | 1.56 | Protein ratios | Hepatocyte | 10 | 3 | 10 | 31 | |
| 2762 | CD99/CD99L2 ratio | PRORT000533 | 1.56 | Protein ratios | Hepatocyte | 56 | 1 | 9 | 15 | |
| 2763 | HNRNPK levels | PROLV000982 | 1.55 | Protein levels | Lymphocyte | 0 | 4 | 10 | 31 | |
| 2764 | RAB27B levels | PROLV001697 | 1.55 | Protein levels | Myeloid | 28 | 2 | 4 | 11 | |
| 2765 | CD244/CD84 ratio | PRORT000405 | 1.55 | Protein ratios | Myeloid | 16 | 1 | 8 | 8 | |
| 2766 | CD84/SEMA4D ratio | PRORT000527 | 1.55 | Protein ratios | Myeloid | 13 | 2 | 5 | 11 | |
| 2767 | UXS1 levels | PROLV002147 | 1.55 | Protein levels | Myeloid | 16 | 2 | 8 | 9 | |
| 2768 | CCL25/PRSS27 ratio | PRORT000353 | 1.54 | Protein ratios | Lymphocyte | 1 | 2 | 9 | 18 | |
| 2769 | Medication, peripheral vascular disease | VASCU000039 | 1.54 | Vascular | Myeloid | 0 | 1 | 5 | 9 | |
| 2770 | CXCL12/TIMP3 ratio | PRORT000821 | 1.54 | Protein ratios | Vascular | 21 | 2 | 6 | 10 | |
| 2771 | TNFRSF11B/TNFSF11 ratio | PRORT001845 | 1.54 | Protein ratios | Hepatocyte | 18 | 1 | 9 | 11 | |
| 2772 | ITGB1BP2/USP8 ratio | PRORT001390 | 1.54 | Protein ratios | Myeloid | 26 | 3 | 10 | 16 | |
| 2773 | GATD3 levels | PROLV000858 | 1.54 | Protein levels | Stromal / connective | 7 | 4 | 8 | 22 | |
| 2774 | NRP1 levels | PROLV001434 | 1.54 | Protein levels | Hepatocyte | 128 | 2 | 10 | 21 | |
| 2775 | C1QTNF1/COL18A1 ratio | PRORT000262 | 1.54 | Protein ratios | B / plasma cell | 6 | 3 | 8 | 18 | |
| 2776 | IL22 levels | PROLV001066 | 1.53 | Protein levels | Melanocyte | 14 | 1 | 6 | 12 | |
| 2777 | Cognitive function | PSYCH000002 | 1.53 | Psychiatric | Neural / glial | 282 | 3 | 5 | 17 | |
| 2778 | VEGFA levels | PROLV002157 | 1.53 | Protein levels | Muscle / cardiac | 30 | 1 | 5 | 14 | |
| 2779 | Depressive symptoms | PSYCH000026 | 1.53 | Psychiatric | Neural / glial | 28 | 2 | 7 | 14 | |
| 2780 | PARP1 levels | PROLV001497 | 1.53 | Protein levels | Lymphocyte | 2 | 6 | 14 | 35 | |
| 2781 | HSPB1 levels | PROLV000997 | 1.53 | Protein levels | Platelet | 16 | 3 | 3 | 13 | |
| 2782 | RPE levels | PROLV001753 | 1.52 | Protein levels | Lymphocyte | 0 | 2 | 15 | 29 | |
| 2783 | SCARF1 levels | PROLV001782 | 1.52 | Protein levels | Lymphocyte | 25 | 3 | 8 | 13 | |
| 2784 | HRG levels | PROLV000988 | 1.52 | Protein levels | Neural / glial | 68 | 4 | 12 | 26 | |
| 2785 | CXCL5/MESD ratio | PRORT000828 | 1.52 | Protein ratios | Lymphocyte | 2 | 3 | 11 | 25 | |
| 2786 | PALM levels | PROLV001489 | 1.52 | Protein levels | Granulosa cell | 28 | 1 | 7 | 8 | |
| 2787 | Hyperthyroidism, autoimmune | IMMUN000014 | 1.52 | Immunologic | Lymphocyte | 60 | 2 | 13 | 28 | |
| 2788 | SLC27A4/TDRKH ratio | PRORT001790 | 1.52 | Protein ratios | Stromal / connective | 0 | 1 | 4 | 11 | |
| 2789 | IL18BP/ROR1 ratio | PRORT001346 | 1.52 | Protein ratios | Myeloid | 6 | 3 | 14 | 30 | |
| 2790 | IL1RL1 levels | PROLV001063 | 1.52 | Protein levels | Stromal / connective | 20 | 1 | 3 | 11 | |
| 2791 | PDGFC levels | PROLV001524 | 1.51 | Protein levels | Hepatocyte | 95 | 2 | 8 | 16 | |
| 2792 | FAM3D levels | PROLV000768 | 1.51 | Protein levels | Epithelial | 7 | 0 | 5 | 8 | |
| 2793 | NGRN levels | PROLV001402 | 1.51 | Protein levels | Myeloid | 0 | 3 | 9 | 13 | |
| 2794 | Enthesopathy | MSKEL000061 | 1.51 | Musculoskeletal | Lymphocyte | 0 | 0 | 1 | 11 | |
| 2795 | Drug poisoning | MISCL000036 | 1.51 | Miscellaneous | Lymphocyte | 11 | 4 | 17 | 34 | |
| 2796 | SCAMP3 levels | PROLV001778 | 1.51 | Protein levels | Vascular | 15 | 2 | 4 | 12 | |
| 2797 | CD84/F2R ratio | PRORT000523 | 1.51 | Protein ratios | Lymphocyte | 20 | 3 | 13 | 33 | |
| 2798 | TBC1D23 levels | PROLV001996 | 1.51 | Protein levels | Muscle / cardiac | 15 | 2 | 8 | 18 | |
| 2799 | CD69/CHMP1A ratio | PRORT000489 | 1.50 | Protein ratios | Hematopoietic progenitor | 1 | 2 | 5 | 13 | |
| 2800 | RGS10 levels | PROLV001730 | 1.50 | Protein levels | Myeloid | 2 | 3 | 6 | 15 | |
| 2801 | BST2/MME ratio | PRORT000254 | 1.50 | Protein ratios | Renal epithelium | 5 | 0 | 6 | 12 | |
| 2802 | Hypercholesterolaemia | METBL000021 | 1.50 | Metabolic | Hepatocyte | 462 | 1 | 7 | 8 | |
| 2803 | HMBS/UBAC1 ratio | PRORT001290 | 1.50 | Protein ratios | Muscle / cardiac | 9 | 1 | 8 | 5 | |
| 2804 | SULT1A1 levels | PROLV001973 | 1.50 | Protein levels | Muscle / cardiac | 31 | 4 | 8 | 23 | |
| 2805 | SRC/TBL1X ratio | PRORT001814 | 1.50 | Protein ratios | Platelet | 1 | 4 | 11 | 15 | |
| 2806 | MATN2 levels | PROLV001277 | 1.50 | Protein levels | Stromal / connective | 78 | 3 | 6 | 14 | |
| 2807 | Ventricular wall thickness | CARDI000016 | 1.49 | Cardiac | Muscle / cardiac | 47 | 2 | 3 | 11 | |
| 2808 | IL22RA2 levels | PROLV001067 | 1.49 | Protein levels | Myeloid | 0 | 2 | 13 | 12 | |
| 2809 | CA11 levels | PROLV000240 | 1.49 | Protein levels | Adipose | 0 | 3 | 6 | 23 | |
| 2810 | CSTB levels | PROLV000553 | 1.49 | Protein levels | Muscle / cardiac | 1 | 1 | 2 | 9 | |
| 2811 | IL7 levels | PROLV001080 | 1.49 | Protein levels | Lymphocyte | 7 | 4 | 10 | 33 | |
| 2812 | DECR1/FXN ratio | PRORT000881 | 1.49 | Protein ratios | Muscle / cardiac | 6 | 5 | 9 | 22 | |
| 2813 | HBEGF/WWP2 ratio | PRORT001272 | 1.49 | Protein ratios | Myeloid | 32 | 3 | 13 | 25 | |
| 2814 | Cirrhosis | HPBIL000006 | 1.48 | Hepatopancreatobiliary | Neural / glial | 9 | 2 | 1 | 4 | |
| 2815 | PPP1R2/USP8 ratio | PRORT001708 | 1.48 | Protein ratios | Hepatocyte | 13 | 3 | 9 | 21 | |
| 2816 | CPXM2 levels | PROLV000512 | 1.48 | Protein levels | Muscle / cardiac | 0 | 2 | 4 | 14 | |
| 2817 | WNT9A levels | PROLV002194 | 1.48 | Protein levels | Muscle / cardiac | 20 | 2 | 6 | 20 | |
| 2818 | TGOLN2 levels | PROLV002024 | 1.48 | Protein levels | Myeloid | 62 | 1 | 4 | 10 | |
| 2819 | CEP20 levels | PROLV000401 | 1.48 | Protein levels | Myeloid | 24 | 3 | 5 | 14 | |
| 2820 | Mosaic chromosomal alteration | MISCL000014 | 1.48 | Miscellaneous | Hematopoietic progenitor | 143 | 3 | 12 | 18 | |
| 2821 | CASP8/PPP3R1 ratio | PRORT000322 | 1.48 | Protein ratios | Lymphocyte | 5 | 1 | 8 | 25 | |
| 2822 | DSC2 levels | PROLV000653 | 1.47 | Protein levels | Epithelial | 35 | 0 | 8 | 8 | |
| 2823 | VGF levels | PROLV002161 | 1.47 | Protein levels | Hepatocyte | 30 | 1 | 5 | 9 | |
| 2824 | PTH1R levels | PROLV001668 | 1.47 | Protein levels | Stromal / connective | 30 | 2 | 6 | 9 | |
| 2825 | HbA1c | METBL000039 | 1.47 | Metabolic | Hematopoietic progenitor | 970 | 0 | 3 | 10 | |
| 2826 | CR2 levels | PROLV000514 | 1.47 | Protein levels | B / plasma cell | 95 | 3 | 9 | 11 | |
| 2827 | CSF1/IFNGR1 ratio | PRORT000776 | 1.46 | Protein ratios | Granulosa cell | 1 | 4 | 8 | 13 | |
| 2828 | PLXNA4/SUSD1 ratio | PRORT001687 | 1.46 | Protein ratios | Lymphocyte | 1 | 2 | 7 | 26 | |
| 2829 | Dermatitis and eczema | DERMA000008 | 1.46 | Dermatologic | Lymphocyte | 129 | 1 | 12 | 18 | |
| 2830 | Benign neoplasm, Skin | MALIG000007 | 1.46 | Malignancy | Melanocyte | 10 | 0 | 5 | 10 | |
| 2831 | GALNT10/SEMA7A ratio | PRORT001202 | 1.46 | Protein ratios | Lymphocyte | 3 | 2 | 11 | 33 | |
| 2832 | PPP1R12A levels | PROLV001613 | 1.46 | Protein levels | Platelet | 20 | 2 | 4 | 15 | |
| 2833 | FCRL1/TREML2 ratio | PRORT001128 | 1.46 | Protein ratios | B / plasma cell | 34 | 2 | 6 | 24 | |
| 2834 | F7/F9 ratio | PRORT001087 | 1.45 | Protein ratios | Hepatocyte | 55 | 1 | 12 | 14 | |
| 2835 | Medication, macular degeneration | OPHTH000015 | 1.45 | Ophthalmic | Hepatocyte | 41 | 3 | 11 | 20 | |
| 2836 | ZBTB16 levels | PROLV002209 | 1.45 | Protein levels | Muscle / cardiac | 43 | 3 | 6 | 15 | |
| 2837 | HSDL2 levels | PROLV000995 | 1.44 | Protein levels | Myeloid | 29 | 1 | 5 | 8 | |
| 2838 | FRZB levels | PROLV000827 | 1.44 | Protein levels | Vascular | 58 | 0 | 7 | 14 | |
| 2839 | Body size, birth | BMORP000017 | 1.44 | Body morphology | Vascular | 12 | 2 | 6 | 9 | |
| 2840 | GALNT5 levels | PROLV000851 | 1.43 | Protein levels | Hematopoietic progenitor | 44 | 4 | 7 | 15 | |
| 2841 | Digestive system disorder | GASTR000006 | 1.43 | Gastrointestinal | Vascular | 60 | 0 | 7 | 16 | |
| 2842 | PFKM levels | PROLV001541 | 1.43 | Protein levels | Lymphocyte | 0 | 3 | 15 | 30 | |
| 2843 | SNAP23/SNAP29 ratio | PRORT001793 | 1.43 | Protein ratios | Lymphocyte | 0 | 3 | 7 | 15 | |
| 2844 | ALCAM/ICAM3 ratio | PRORT000071 | 1.43 | Protein ratios | Hepatocyte | 12 | 2 | 6 | 14 | |
| 2845 | Brain structural connectivity | NIMAG000007 | 1.43 | Neuroimaging | Neural / glial | 35 | 0 | 0 | 0 | |
| 2846 | Skin keratoses, actinic | DERMA000021 | 1.43 | Dermatologic | Lymphocyte | 211 | 2 | 10 | 23 | |
| 2847 | Polyglandular dysfunction | IMMUN000037 | 1.43 | Immunologic | B / plasma cell | 0 | 3 | 10 | 21 | |
| 2848 | MMP10 levels | PROLV001322 | 1.43 | Protein levels | Epithelial | 12 | 0 | 6 | 7 | |
| 2849 | PPME1 levels | PROLV001612 | 1.43 | Protein levels | Vascular | 9 | 4 | 12 | 31 | |
| 2850 | BTC levels | PROLV000217 | 1.43 | Protein levels | Hematopoietic progenitor | 10 | 6 | 9 | 18 | |
| 2851 | PTPRF levels | PROLV001675 | 1.43 | Protein levels | Hepatocyte | 213 | 1 | 5 | 9 | |
| 2852 | FAM171B levels | PROLV000761 | 1.42 | Protein levels | Muscle / cardiac | 12 | 2 | 4 | 8 | |
| 2853 | Spermatocele | REPRO000014 | 1.42 | Reproductive | Epithelial | 8 | 0 | 5 | 12 | |
| 2854 | SELP levels | PROLV001805 | 1.42 | Protein levels | Neural / glial | 40 | 5 | 8 | 14 | |
| 2855 | EDAR levels | PROLV000674 | 1.42 | Protein levels | Hematopoietic progenitor | 11 | 2 | 4 | 9 | |
| 2856 | Intracranial volume | NIMAG000025 | 1.42 | Neuroimaging | Muscle / cardiac | 0 | 3 | 8 | 18 | |
| 2857 | DBNL/EDAR ratio | PRORT000865 | 1.42 | Protein ratios | Myeloid | 31 | 4 | 14 | 22 | |
| 2858 | SFTPA1 levels | PROLV001847 | 1.42 | Protein levels | B / plasma cell | 0 | 0 | 3 | 9 | |
| 2859 | Anorexia nervosa | PSYCH000011 | 1.42 | Psychiatric | Myeloid | 0 | 1 | 8 | 7 | |
| 2860 | EGLN1/PSIP1 ratio | PRORT001005 | 1.41 | Protein ratios | Myeloid | 0 | 0 | 3 | 8 | |
| 2861 | PDGFB/UXS1 ratio | PRORT001651 | 1.41 | Protein ratios | Hepatocyte | 17 | 3 | 9 | 22 | |
| 2862 | Meat preference | DTSUP000015 | 1.41 | Diet and Supplement | Neural / glial | 47 | 5 | 12 | 14 | |
| 2863 | BANK1 levels | PROLV000178 | 1.41 | Protein levels | Myeloid | 33 | 2 | 5 | 13 | |
| 2864 | SORD levels | PROLV001920 | 1.41 | Protein levels | Hepatocyte | 44 | 1 | 4 | 11 | |
| 2865 | PTN levels | PROLV001669 | 1.41 | Protein levels | Hepatocyte | 35 | 5 | 12 | 30 | |
| 2866 | IL19 levels | PROLV001058 | 1.40 | Protein levels | Vascular | 20 | 0 | 7 | 23 | |
| 2867 | GNLY levels | PROLV000905 | 1.40 | Protein levels | Lymphocyte | 91 | 2 | 14 | 32 | |
| 2868 | ATP5IF1/FXN ratio | PRORT000157 | 1.40 | Protein ratios | Hepatocyte | 7 | 4 | 12 | 21 | |
| 2869 | INPPL1 levels | PROLV001091 | 1.40 | Protein levels | Vascular | 17 | 3 | 10 | 24 | |
| 2870 | GLT25D1 levels | PROLV000899 | 1.40 | Protein levels | Vascular | 0 | 1 | 4 | 5 | |
| 2871 | DNAJB1/EIF4B ratio | PRORT000926 | 1.39 | Protein ratios | Hepatocyte | 28 | 2 | 6 | 11 | |
| 2872 | FOXO1/IRAK4 ratio | PRORT001172 | 1.39 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 29 | |
| 2873 | Benign neoplasm, Adipose | MALIG000001 | 1.39 | Malignancy | Adipose | 1 | 2 | 6 | 14 | |
| 2874 | POMC levels | PROLV001599 | 1.39 | Protein levels | B / plasma cell | 28 | 1 | 3 | 12 | |
| 2875 | DAB2/FKBP1B ratio | PRORT000836 | 1.39 | Protein ratios | Muscle / cardiac | 0 | 4 | 12 | 37 | |
| 2876 | MBL2 levels | PROLV001282 | 1.39 | Protein levels | B / plasma cell | 15 | 2 | 7 | 23 | |
| 2877 | NAAA levels | PROLV001369 | 1.39 | Protein levels | Hepatocyte | 124 | 1 | 5 | 11 | |
| 2878 | CIAPIN1/SNX9 ratio | PRORT000617 | 1.39 | Protein ratios | Vascular | 0 | 4 | 15 | 42 | |
| 2879 | PTPRF/SDC1 ratio | PRORT001722 | 1.38 | Protein ratios | Hepatocyte | 59 | 1 | 7 | 9 | |
| 2880 | APP/EGF ratio | PRORT000124 | 1.38 | Protein ratios | Vascular | 6 | 5 | 17 | 39 | |
| 2881 | Vaccination adverse effects | IMMUN000008 | 1.38 | Immunologic | Muscle / cardiac | 0 | 3 | 7 | 37 | |
| 2882 | Family history, chronic lung disease | RESPI000002 | 1.38 | Respiratory | Stromal / connective | 0 | 2 | 6 | 14 | |
| 2883 | BCAM/PCDH17 ratio | PRORT000212 | 1.38 | Protein ratios | Granulosa cell | 32 | 2 | 8 | 14 | |
| 2884 | SMPD1 levels | PROLV001901 | 1.38 | Protein levels | Hepatocyte | 179 | 1 | 7 | 16 | |
| 2885 | OPLAH levels | PROLV001471 | 1.37 | Protein levels | Lymphocyte | 8 | 0 | 7 | 13 | |
| 2886 | Occupational attainment | SOCIO000007 | 1.37 | Socioeconomic | Myeloid | 6 | 5 | 7 | 20 | |
| 2887 | SNX9 levels | PROLV001915 | 1.37 | Protein levels | Vascular | 12 | 1 | 4 | 20 | |
| 2888 | PADI2 levels | PROLV001483 | 1.37 | Protein levels | B / plasma cell | 4 | 1 | 3 | 8 | |
| 2889 | SDCCAG8 levels | PROLV001798 | 1.37 | Protein levels | Myeloid | 1 | 2 | 3 | 12 | |
| 2890 | Eustachian tube disorder | AUDIO000015 | 1.36 | Auditory | Epithelial | 0 | 0 | 6 | 8 | |
| 2891 | Parental longevity | AGING000003 | 1.36 | Aging | Neural / glial | 8 | 1 | 2 | 16 | |
| 2892 | Hair characteristics | DERMA000031 | 1.36 | Dermatologic | Adipose | 1 | 1 | 1 | 0 | |
| 2893 | Rheumatoid arthritis, RA | IMMUN000019 | 1.36 | Immunologic | Lymphocyte | 250 | 2 | 16 | 11 | |
| 2894 | CD48/CRTAM ratio | PRORT000463 | 1.36 | Protein ratios | Lymphocyte | 45 | 2 | 15 | 25 | |
| 2895 | FOLH1 levels | PROLV000821 | 1.36 | Protein levels | Hepatocyte | 7 | 0 | 3 | 10 | |
| 2896 | APP/CD40LG ratio | PRORT000122 | 1.36 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 13 | 32 | |
| 2897 | Nephrotic syndrome | NEPHR000011 | 1.36 | Nephrourologic | B / plasma cell | — | 3 | 8 | 28 | |
| 2898 | SNX9/VASH1 ratio | PRORT001802 | 1.35 | Protein ratios | Stromal / connective | 0 | 2 | 3 | 9 | |
| 2899 | GALNT3 levels | PROLV000850 | 1.35 | Protein levels | Vascular | 35 | 2 | 5 | 8 | |
| 2900 | Menopausal disorder | REPRO000020 | 1.35 | Reproductive | Hepatocyte | 0 | 5 | 9 | 25 | |
| 2901 | DKK4/REG1B ratio | PRORT000910 | 1.35 | Protein ratios | Hepatocyte | 27 | 1 | 10 | 15 | |
| 2902 | SNAP29/VEGFC ratio | PRORT001800 | 1.35 | Protein ratios | Lymphocyte | 5 | 2 | 8 | 38 | |
| 2903 | SPINK2 levels | PROLV001928 | 1.35 | Protein levels | Lymphocyte | 29 | 4 | 16 | 31 | |
| 2904 | Ventricular function | CARDI000008 | 1.34 | Cardiac | Muscle / cardiac | 84 | 2 | 4 | 12 | |
| 2905 | EDAR/TACC3 ratio | PRORT000980 | 1.34 | Protein ratios | Myeloid | 9 | 3 | 14 | 21 | |
| 2906 | AAGAB levels | PROLV000003 | 1.34 | Protein levels | Hepatocyte | 3 | 1 | 8 | 17 | |
| 2907 | Food preparation preference | DTSUP000021 | 1.34 | Diet and Supplement | Neural / glial | 51 | 4 | 9 | 6 | |
| 2908 | Operation, urological | NEPHR000016 | 1.34 | Nephrourologic | Vascular | 16 | 0 | 6 | 18 | |
| 2909 | Immune cell marker, Monocyte | HEMAT000027 | 1.34 | Hematologic | Myeloid | 15 | 2 | 9 | 12 | |
| 2910 | S100A4/SNAP29 ratio | PRORT001755 | 1.34 | Protein ratios | Hepatocyte | 6 | 1 | 8 | 19 | |
| 2911 | CTF1/ITGB1BP2 ratio | PRORT000793 | 1.33 | Protein ratios | Hematopoietic progenitor | 18 | 4 | 10 | 21 | |
| 2912 | ICA1/TANK ratio | PRORT001320 | 1.33 | Protein ratios | Neural / glial | 0 | 3 | 4 | 9 | |
| 2913 | A4GALT levels | PROLV000002 | 1.33 | Protein levels | Vascular | 7 | 0 | 2 | 1 | |
| 2914 | PRTN3 levels | PROLV001651 | 1.33 | Protein levels | Myeloid | 93 | 1 | 5 | 9 | |
| 2915 | BCR/ICA1 ratio | PRORT000226 | 1.33 | Protein ratios | Hepatocyte | 0 | 1 | 4 | 23 | |
| 2916 | ROR1/THBD ratio | PRORT001747 | 1.33 | Protein ratios | Lymphocyte | 10 | 3 | 14 | 38 | |
| 2917 | CD59/CST6 ratio | PRORT000481 | 1.33 | Protein ratios | Respiratory epithelium | 3 | 0 | 12 | 7 | |
| 2918 | PRND levels | PROLV001636 | 1.32 | Protein levels | Vascular | 49 | 4 | 10 | 21 | |
| 2919 | CALB1 levels | PROLV000253 | 1.32 | Protein levels | Hepatocyte | 6 | 1 | 10 | 15 | |
| 2920 | Medication, angiotensin receptor blocker | VASCU000029 | 1.32 | Vascular | Adipose | 0 | 1 | 8 | 19 | |
| 2921 | Skin and subcutaneous tissue disorder | DERMA000004 | 1.32 | Dermatologic | Muscle / cardiac | 0 | 0 | 0 | 0 | |
| 2922 | Alcohol use disorder | PSYCH000044 | 1.32 | Psychiatric | Neural / glial | 2 | 3 | 5 | 12 | |
| 2923 | PILRA/TNFRSF1A ratio | PRORT001668 | 1.32 | Protein ratios | Adipose | 42 | 2 | 9 | 13 | |
| 2924 | COMT levels | PROLV000497 | 1.32 | Protein levels | Vascular | 9 | 6 | 11 | 23 | |
| 2925 | GZMB levels | PROLV000948 | 1.32 | Protein levels | Lymphocyte | 108 | 3 | 14 | 28 | |
| 2926 | TARBP2 levels | PROLV001993 | 1.32 | Protein levels | Vascular | 16 | 2 | 6 | 19 | |
| 2927 | FGFR2 levels | PROLV000801 | 1.32 | Protein levels | Adipose | 45 | 0 | 5 | 11 | |
| 2928 | RRM2B/SMAD1 ratio | PRORT001749 | 1.31 | Protein ratios | Hepatocyte | 1 | 1 | 5 | 18 | |
| 2929 | Facial nerve palsy | NEURO000026 | 1.31 | Neurologic | Neural / glial | 0 | 1 | 9 | 27 | |
| 2930 | MGAT2 levels | PROLV001308 | 1.31 | Protein levels | Neural / glial | 2 | 4 | 11 | 21 | |
| 2931 | Lysine metabolites | METAB000009 | 1.31 | Metabolites | Lymphocyte | 6 | 1 | 3 | 20 | |
| 2932 | Hyperthyroidism | ENDOC000020 | 1.30 | Endocrine | Lymphocyte | 62 | 1 | 10 | 16 | |
| 2933 | CD74/TNFRSF21 ratio | PRORT000508 | 1.30 | Protein ratios | Vascular | 30 | 2 | 8 | 15 | |
| 2934 | SERPINB1/SERPINB6 ratio | PRORT001773 | 1.30 | Protein ratios | Myeloid | 2 | 3 | 7 | 15 | |
| 2935 | CD79B/CKAP4 ratio | PRORT000509 | 1.30 | Protein ratios | B / plasma cell | 35 | 2 | 8 | 8 | |
| 2936 | GAL levels | PROLV000847 | 1.29 | Protein levels | Hepatocyte | 129 | 1 | 11 | 16 | |
| 2937 | GP6/HPCAL1 ratio | PRORT001232 | 1.29 | Protein ratios | Lymphocyte | 1 | 3 | 13 | 26 | |
| 2938 | FURIN/INHBC ratio | PRORT001184 | 1.29 | Protein ratios | Hepatocyte | 45 | 1 | 8 | 23 | |
| 2939 | CD40LG levels | PROLV000341 | 1.28 | Protein levels | Myeloid | 31 | 4 | 7 | 15 | |
| 2940 | TIMP4 levels | PROLV002040 | 1.28 | Protein levels | Myeloid | 28 | 1 | 4 | 6 | |
| 2941 | MED18/SH2B3 ratio | PRORT001508 | 1.28 | Protein ratios | Hepatocyte | 5 | 5 | 8 | 30 | |
| 2942 | Female genital disorder | REPRO000006 | 1.28 | Reproductive | Stromal / connective | 14 | 4 | 9 | 13 | |
| 2943 | Brain age gap | NIMAG000004 | 1.28 | Neuroimaging | Neural / glial | 1 | 4 | 15 | 36 | |
| 2944 | ARHGAP1 levels | PROLV000135 | 1.27 | Protein levels | Myeloid | 5 | 1 | 8 | 12 | |
| 2945 | ENG/NOTCH1 ratio | PRORT001018 | 1.27 | Protein ratios | Vascular | 3 | 2 | 7 | 16 | |
| 2946 | NQO2 levels | PROLV001430 | 1.27 | Protein levels | Muscle / cardiac | 22 | 1 | 6 | 13 | |
| 2947 | CRACR2A/LBR ratio | PRORT000741 | 1.26 | Protein ratios | Myeloid | 0 | 3 | 17 | 17 | |
| 2948 | Weight, birth | BMORP000018 | 1.26 | Body morphology | Vascular | 117 | 2 | 6 | 16 | |
| 2949 | KLRF1 levels | PROLV001163 | 1.26 | Protein levels | Lymphocyte | 134 | 3 | 14 | 15 | |
| 2950 | HEPACAM2 levels | PROLV000962 | 1.26 | Protein levels | Epithelial | 121 | 1 | 9 | 11 | |
| 2951 | CCN2/VEGFC ratio | PRORT000371 | 1.26 | Protein ratios | Hematopoietic progenitor | 24 | 4 | 9 | 19 | |
| 2952 | ERBIN levels | PROLV000727 | 1.26 | Protein levels | Neural / glial | 8 | 6 | 6 | 10 | |
| 2953 | Spondylolisthesis or spondylolysis | MSKEL000079 | 1.26 | Musculoskeletal | Stromal / connective | 0 | 3 | 5 | 13 | |
| 2954 | ZBTB17 levels | PROLV002210 | 1.26 | Protein levels | Muscle / cardiac | 8 | 4 | 9 | 21 | |
| 2955 | PRR4 levels | PROLV001642 | 1.26 | Protein levels | Epithelial | 44 | 0 | 8 | 9 | |
| 2956 | DFFA/SIRT2 ratio | PRORT000888 | 1.25 | Protein ratios | Hepatocyte | 21 | 3 | 11 | 15 | |
| 2957 | PON2 levels | PROLV001601 | 1.25 | Protein levels | Hepatocyte | 91 | 2 | 9 | 17 | |
| 2958 | SORT1/ST6GAL1 ratio | PRORT001803 | 1.25 | Protein ratios | B / plasma cell | 24 | 5 | 11 | 22 | |
| 2959 | ADM levels | PROLV000051 | 1.25 | Protein levels | B / plasma cell | 52 | 1 | 6 | 13 | |
| 2960 | TST levels | PROLV002117 | 1.25 | Protein levels | Neural / glial | 2 | 2 | 5 | 15 | |
| 2961 | Fibromuscular dysplasia | VASCU000024 | 1.25 | Vascular | Stromal / connective | 1 | 3 | 6 | 11 | |
| 2962 | CLEC4D/TGFA ratio | PRORT000657 | 1.24 | Protein ratios | Myeloid | 4 | 1 | 6 | 7 | |
| 2963 | FUT8 levels | PROLV000839 | 1.24 | Protein levels | Myeloid | 28 | 3 | 8 | 30 | |
| 2964 | SPRY2 levels | PROLV001940 | 1.24 | Protein levels | Lymphocyte | 16 | 3 | 10 | 23 | |
| 2965 | CCL25 levels | PROLV000292 | 1.24 | Protein levels | Vascular | 127 | 0 | 2 | 11 | |
| 2966 | GLB1/GUSB ratio | PRORT001215 | 1.24 | Protein ratios | Hepatocyte | 40 | 2 | 8 | 12 | |
| 2967 | DBNL levels | PROLV000599 | 1.24 | Protein levels | Lymphocyte | 3 | 4 | 10 | 25 | |
| 2968 | MIA/NBL1 ratio | PRORT001532 | 1.24 | Protein ratios | Stromal / connective | 22 | 3 | 7 | 17 | |
| 2969 | BCAM/ICAM4 ratio | PRORT000209 | 1.24 | Protein ratios | Hematopoietic progenitor | 1 | 3 | 9 | 21 | |
| 2970 | Hip circumference | BMORP000011 | 1.23 | Body morphology | Neural / glial | 496 | 4 | 9 | 26 | |
| 2971 | CKAP4/IL4R ratio | PRORT000620 | 1.23 | Protein ratios | Hepatocyte | 33 | 2 | 13 | 18 | |
| 2972 | MAP3K5/MAVS ratio | PRORT001488 | 1.23 | Protein ratios | B / plasma cell | 7 | 3 | 12 | 15 | |
| 2973 | ERBIN/TBC1D23 ratio | PRORT001052 | 1.23 | Protein ratios | Hepatocyte | 0 | 4 | 9 | 17 | |
| 2974 | SH2D1A levels | PROLV001852 | 1.23 | Protein levels | Lymphocyte | 41 | 2 | 10 | 28 | |
| 2975 | NECTIN4/TGFBR2 ratio | PRORT001584 | 1.23 | Protein ratios | Epithelial | 18 | 0 | 6 | 12 | |
| 2976 | TRIM24 levels | PROLV002107 | 1.23 | Protein levels | Muscle / cardiac | 1 | 3 | 6 | 15 | |
| 2977 | Retirement wellbeing | SOCIO000027 | 1.23 | Socioeconomic | Neural / glial | 1 | 5 | 6 | 12 | |
| 2978 | FXN levels | PROLV000840 | 1.23 | Protein levels | Platelet | 13 | 2 | 4 | 9 | |
| 2979 | CLC/RNASE3 ratio | PRORT000625 | 1.22 | Protein ratios | Myeloid | 7 | 1 | 5 | 9 | |
| 2980 | Valvular heart disease | CARDI000054 | 1.22 | Cardiac | Vascular | 15 | 5 | 9 | 24 | |
| 2981 | Hair pigmentation | DERMA000025 | 1.22 | Dermatologic | Melanocyte | 189 | 2 | 7 | 22 | |
| 2982 | LGALS8 levels | PROLV001206 | 1.22 | Protein levels | Vascular | 13 | 3 | 8 | 21 | |
| 2983 | SERPINF1 levels | PROLV001832 | 1.22 | Protein levels | Vascular | 7 | 0 | 6 | 8 | |
| 2984 | Circadian timing | BEHAV000014 | 1.22 | Behavioural | Neural / glial | 79 | 2 | 9 | 16 | |
| 2985 | Eosinophil | HEMAT000030 | 1.22 | Hematologic | Lymphocyte | 1,935 | 2 | 16 | 25 | |
| 2986 | CALCOCO2 levels | PROLV000258 | 1.21 | Protein levels | Vascular | 11 | 4 | 5 | 16 | |
| 2987 | Kidney failure, acute | NEPHR000012 | 1.21 | Nephrourologic | Lymphocyte | 0 | 2 | 15 | 24 | |
| 2988 | PPT1 levels | PROLV001621 | 1.21 | Protein levels | Melanocyte | 2 | 3 | 7 | 26 | |
| 2989 | SCARF1/SUSD1 ratio | PRORT001761 | 1.21 | Protein ratios | Myeloid | 4 | 2 | 8 | 16 | |
| 2990 | ANCA-associated vasculitis | IMMUN000021 | 1.21 | Immunologic | Adipose | 2 | 0 | 1 | 4 | |
| 2991 | FLT3/FLT3LG ratio | PRORT001165 | 1.21 | Protein ratios | Lymphocyte | 5 | 5 | 11 | 30 | |
| 2992 | SDC4 levels | PROLV001797 | 1.21 | Protein levels | Hematopoietic progenitor | 103 | 3 | 7 | 20 | |
| 2993 | BCR/VASH1 ratio | PRORT000230 | 1.21 | Protein ratios | Hepatocyte | 1 | 1 | 6 | 13 | |
| 2994 | CD58 levels | PROLV000346 | 1.21 | Protein levels | Granulosa cell | 82 | 2 | 7 | 13 | |
| 2995 | Cancer, General | MALIG000015 | 1.20 | Malignancy | Myeloid | 29 | 0 | 1 | 2 | |
| 2996 | Seafood preference | DTSUP000016 | 1.20 | Diet and Supplement | Neural / glial | 76 | 3 | 5 | 10 | |
| 2997 | FCRL2/LY9 ratio | PRORT001130 | 1.20 | Protein ratios | B / plasma cell | 27 | 2 | 8 | 38 | |
| 2998 | CCL5/SELP ratio | PRORT000358 | 1.20 | Protein ratios | Lymphocyte | 2 | 1 | 6 | 32 | |
| 2999 | EIF4G1/FKBP5 ratio | PRORT001008 | 1.20 | Protein ratios | Hepatocyte | 20 | 1 | 6 | 10 | |
| 3000 | LY96/ST6GAL1 ratio | PRORT001471 | 1.20 | Protein ratios | Hepatocyte | 11 | 3 | 7 | 10 |